February 2020 Volume 12 Issue 2 PHARMACYNEWSIRELAND.COM
THE INDEPENDENT VOICE OF PHARMACY
In this issue:
LOOKING FOR A BETTER NIGHT’S SLEEP?
NEWS: Elections loom, what’s on Pharmacy agenda? Page 5
EVENT: Stacks Pharmacy train staff on CPD Page 9
REPORT: Medicine Shortages impacting Pharmacy Page 14
FEATURE: Topical Analgesics Page 28
DISCOVER NYTOL’S FIRST * CLINICALLY PROVEN SLEEP AID
Dermatitis Page 36
*New to Nytol range in Ireland. Nytol One-A-Night 50 mg Tablets contains diphenhydramine hydrochloride. A symptomatic aid to the relief of temporary sleep disturbance in adults. Adults: One tablet to be taken 20 minutes before going to bed, or as directed by a physician. Do not exceed the maximum dose of one tablet in 24 hours. Elderly patients or patients with liver or kidney problems should consult their doctor before taking this medicine. Children under 18 years: Not recommended. The product should not be taken for more than 7 days without consulting a doctor. Contraindications: hypersensitivity to the active substance or to any of the excipients, stenosing peptic ulcer, pyloroduodenal obstruction, phaeochromocytoma, known acquired or congenital QT interval prolongation, known risk factors for QT interval prolongation. Special warnings and precautions: pregnancy/lactation, renal and hepatic impairment, myasthenia gravis, epilepsy or seizure disorders, narrow-angle glaucoma, prostatic hypertrophy, urinary retention, asthma, bronchitis, COPD. Patients should be advised to promptly report any cardiac symptoms. Do not take for more than 7 consecutive nights without consulting a doctor. Use in the elderly should be avoided. Avoid concomitant use of alcohol or other antihistamine-containing preparations. Do not drive or operate machines. Interactions: CNS depressants, MAO inhibitors, anticholinergic drugs (e.g. atropine, tricyclic antidepressants), metoprolol and venlafaxine, CYP2D6 inhibitors, Class Ia and Class III anti-arrhythmics. Side effects: thrombocytopenia, hypersensitivity reactions, confusion, paradoxical excitation, sedation, drowsiness, disturbance in attention, unsteadiness, dizziness, convulsions, headache, paraesthesia, dyskinesias, blurred vision, tachycardia, palpitations, thickening of bronchial secretions, dry mouth, gastrointestinal disturbance, muscle twitching, urinary difficulty, urinary retention, fatigue. Legal classification: P: PA1186/016/001. MAH: Chefaro Ireland DAC. The Sharp Building. Hogan Place. Dublin 2. Ireland. RRP (ex. VAT): 20s €7.99. SPC: https://www.medicines.ie/medicines/nytol-one-a-night-50-mg-tablets-34889/smpc IRE-NYT-2019-013
Nytol_OAN_KV_TRADE V2 IPU.indd 1
OTC AWARDS: The Product Finalists for 2020 Page 47
*Revive & Go Immunity contains Vitamin C, which contributes to the normal function of the immune system. B12-Max contains Vitamin B12, which contributes to normal energy yielding metabolism. Q10-Max contains Vitamin B1, which contributes to normal energy yielding metabolism. D3-Max contains Vitamin D to support normal function of the immune system.
Exclusive to health stores and pharmacies
Supporting Wellbeing, Immunity & Energy *
NT BASE LA
Page 4: Ballymun Pharmacist stands for election
Election campaigning is well underway across Ireland and now more than ever it is crucial community pharmacy are heard as a profession. It is vital pharmacists are engaging with the main parties to ensure issues affecting them, and their teams, are front and centre.
Page 9: Stacks further staff development
On page 12 of this issue, we take a brief look at what some of these parties are promising with regards to health and pharmacy.
Page 12: What of pharmacy is on the political agenda?
As the general election gathered momentum, the Irish Pharmaceutical Healthcare Association (IPHA) has also urged all political parties to pledge to improve patients’ access to new medicines as part of their plans for health.
Page 14: Medicine Shortages crisis continues
Page 18: Meningitis B Vaccine rate on upward climb
Oliver O’Connor, the Chief Executive of IPHA, said the industry is clear that there is a better way possible.
Page 38: Corporate Profile with Tom Freyne Page 47: OTC Retail & Pharmacy Product Awards 2020
PUBLISHER: IPN Communications Ireland Ltd. Clifton House, Fitzwilliam Street Lower, Dublin 2 - 00353 (01) 6690562 MANAGING DIRECTOR Natalie Maginnis firstname.lastname@example.org EDITOR Kelly Jo Eastwood: 00353 (87)737 6308 email@example.com ADVERTISING DIRECTOR Debbie Graham: 00353 (87) 288 2371 firstname.lastname@example.org ADVERTISING EXECUTIVE Amy Evans: email@example.com DESIGN DIRECTOR Ian Stoddart Design
Ireland remains among the slowest in Western Europe to provide new medicines to patients. In the last Dáil, we saw patients groups regularly having to protest for access to new medicines. Ministers ended up making political decisions on medicines. At the same time, very large savings, price cuts and cash rebates are still being provided by pharmaceutical companies to the HSE.
“First, political parties should pledge to improve patients’ access to new medicines and assure them that protesting for medicines will be a thing of the past. In other news, on page 14 we take a look at how medicine shortages are is an increasing problem. Community pharmacists are very concerned about this phenomenon, which can compromise patients’ health. Moreover, pharmacies and pharmacists invest a lot of resources dealing with shortages which constitutes not only a financial burden but also a loss of opportunity to spend time with other patient-centred tasks and to improve the quality of care. Each year, the Pharmaceutical Group of the European Union conducts a survey among its membership to map the impact of medicine shortages across Europe from the community pharmacists’ perspective.
47 Irish Pharmacy IRISH News is PHARMACY circulated to all NEWS independent, multiple Pharmacists and academics in Ireland. All rights reserved by Irish Pharmacy News. All material published in Irish Pharmacy News is copyright and no part of this magazine may be reproduced, stored in a retrieval system or transmitted in any form without written permission. IPN Communications Ltd. has taken every care in compiling the magazine to ensure that it is correct at the time of going to press, however the publishers assume no responsibility for any effects from omissions or errors.
The 2019 survey shows that in the past 12 months, and the vast majority (87%) of respondents indicated that the situation got worse compared to 2018 and that all classes of medicines are affected by medicine shortages in community pharmacies. Stacks Pharmacy are just one of a number of pharmacy groups who understand that their staff is at the heart of the company. With this in mind they recently organised a CPD training event. Turn to page 22 to read more about it.
Regulars FEATURE: TOPICAL ANALGESICS
TEAM TRAINING: DERMATITIS
0044 (0) 28 4066 2511
Sole Distributor in Ireland @GoshCosmeticsIrl
¤6m development for McGreals Pharmacy McGreals Pharmacy have lodged plans for a new 33,000 square foot medical centre in Naas. Image of proposed new development
It’s being developed by McGreals group whose interests include a number of pharmacies in the area.
The development will include a pharmacy, as well as a retail unit and a convenience store. The proposal is at the very early planning stages with Kildare County Council. The plan has been lodged by Star Primary Care and it seeks to demolish an existing building,
which is a former auction room and offices. Permission is sought for a new three storey over basement building and there will also be a basement car park. The development will consist of two floors of medical suites as well as three retail units and surface and underground parking.
Kilian McGreal says, "We intend to build a state of the art, patient care focussed healthcare facility on the site of the old Ashgrove auctions premises. A huge amount of work has been put into not only the design of the building, but also engaging with GPs and healthcare providers to ensure the services which are most needed are available in the Naas area." It’s understood there will be numerous medical consultation suites between the first and second floors. It’s also understood the state-of-the-art centre will cost about ¤6m.
Pharmacist Edward stands for Election Castleknock community pharmacist Edward McManus is standing in the general election for new political party Aontú.
Pharmacy – Know your Value The General Election is getting very close, and electioneering is now in full swing. Many are working hard to ensure that community pharmacy is at the forefront of the political parties agendas. The IPU, as part of their ongoing activities, is engaging with all the main political parties to ensure issues affecting community pharmacy are front and centre. While it is obviously important that the IPU continues to engage with the political candidates, it is also crucial that community pharmacists use this opportunity to engage with politicians in their locality as well. Pharmacists are being encouraged to use every opportunity to engage with local candidates. There are a number of ways you can do this: • Your pharmacy window: The more visible our campaign is, the stronger it is; • Have copies of the message sheet ready: This provides information on pharmacy’s key issues. Have copies ready to give to canvassers who call to your home and pharmacy; • Contact your local candidates: and • Use social media: o If you meet a candidate in person, ask if you can take a photo with them, which you can then post on social media with the hashtags #SupportPharmacy and #GE2020, and tag the IPU’s account;
Edward McManus, McManus Pharmacy, Ballymun Edward, a pharmacist and community activist runs the McManus Pharmacy in Ballymun town Shopping Centre. He has served as Chair of the Blanchardstown Local Drug and Alcohol Task Force from 2014 to
2018. He has served as secretary to the Castleknock Residents Action Group. Edward is the current Chair of the Castleknock Parish Council. Edward is also a member of Castleknock Tidy Towns Committee. Meanwhile, Aontú leader Peadar Tóibín has made it clear that Aontú will support the forthcoming motion of no confidence in Simon Harris as Minister for Health when the Dáil resumes. An Teachta Tóibín TD stated,
“Simon Harris’ record is clear. He has been at the helm of the Irish health system since 2016 and hundreds of thousands of Irish people are suffering pain, serious immobility and damaging long-term ill health as a direct result of the crumbling Irish health system and the confused maladministration of Simon Harris. “Just this week, there was a record-breaking 760 patients on A&E hospital trolleys waiting for treatment.”
o Twitter handles for all candidates are also on the IPU website. The IPU is @IrishPharmacy on Twitter; @IrishPharmacyUnion on Facebook; @Irish Pharmacy Union on LinkedIn; and @irishpharmacyunion on Instagram. The message sheet provides an overview of the key issues, and there are further details of these issues in the policy booklet, which is also on the IPU website. Hard copies of the message sheet, policy document and poster have been posted and should be with you shortly.
News Crime against Pharmacy Crime levels towards community pharmacy continue to rise. Irish Pharmacy News has learned this month of at least two attacks. Gardaí have recently arrested two men in connection with two separate robberies at retail premises in Dublin last month. The first occurred at a shop on the Lower Rathmines Road, where a man armed with a knife demanded cash from staff. He left without taking anything. A 23-year-old man was arrested a short time later and taken to Terenure garda station. In the second incident, gardaí were notified of a robbery at a pharmacy on Johnstown Road in Cabinteely. A man entered the shop armed with a knife and demanded items. Both men were scheduled to appear before the Criminal Courts of Justice in Dublin in connection with these incidents.
Ireland slowest for new Medicines Ireland is among the slowest in western Europe to provide new medicines to patients. Patients in Ireland are waiting three times as long to get the same medicines, including cancer drugs, as patients in other comparable European countries. Updated analysis from the Irish Pharmaceutical Healthcare Association (IPHA) has found that 13 medicines, eight of which are for cancer, have been waiting for 926 days and counting to be reimbursed and made available to patients.
has not been made available, preventing access by patients.
Even though all the medicines have completed the full pharmacoeconomic process and some have received reimbursement approval, funding
IPHA is calling on all parties to pledge to improve patients’ access to new medicines through policy.
This compares to an average of 289 days from date of EMA licensing in 10 other European countries in which the medicines are available.
On World Cancer Day,
biopharmaceutical innovators have urged politicians to make faster access to innovative new medicines a Programme for Government priority when it is negotiated after the General Election. IPHA has said the political leaders who form a new Government should adopt an explicit policy on how to allocate funding to new medicines, relying on both the State and industry contributions.
Pharmacies run out of Face Masks Community pharmacies across Ireland seen a surge in demand for surgical face masks from customers since the outbreak of the coronavirus in China, with some stores in the capital running out of these products entirely.
Meanwhile, a man armed with a bicycle saddle who robbed a Dublin pharmacy, where a 70-year-old woman who knew his family was working, has been jailed for two-and-a-half years. Ross Hutch (27), of Portland Place, Dublin 1 pleaded guilty at Dublin Circuit Criminal Court to robbing ¤200 from Boles Pharmacy in Drumcondra on 12 April last. Passing sentence today, Judge Martin Nolan said the Hutch family had used the pharmacy and the injured party knew the family well. The Irish Pharmacy Union (IPU) Crime Survey last year revealed that pharmacies across the country are under siege due to the high levels of crime they are subject too. Three quarters of all pharmacies have been the victim of at least one crime over the past twelve months, with the majority of these (81%) experiencing multiple incidents. The IPU has called for more resources to be made available to tackle crime in the community or warned that these high levels of crime will continue.
According to The Journal, suppliers are also under pressure and pharmacists who are sold out of face masks say they are not sure when they will be able to restock them. It is believed over 500 people have now died from the coronavirus, which originated in the Chinese city of Wuhan but it has spread to around a dozen countries. There are severe shortages of surgical face masks in China, where people are being encouraged to wear them to help prevent the spread of the virus. The majority of the confirmed cases (almost 2,000) have been in China. It is understood there has been a spike in consumers requesting face masks with many community pharmacies seeing a dramatic increase in demand. Some pharmacists have said that
while it is a unique and unusual product request, many people are wondering if they should purchase them. “Once the news of the coronavirus was out, we had a lot of people coming in to buy them,” a Dublin pharmacist told The Journal. “When we ran out, we tried to reorder them from the supplier but there’s a shortage there. “The demand definitely went up after the news broke, and it’s not something we would normally sell out of that fast,” another pharmacist said.
“We’re waiting for the supplier to come back to us now because we don’t have any left. “Over the weekend we had a lot of people buying them, some people who were planning to travel, and there were also people just asking about them, even if they weren’t buying – just checking whether we had any.” A number of Boots pharmacies have run out of the masks and the retailer’s website states that its box of surgical masks is sold out. It also states the retailer “won’t be receiving any further stock.”
New Medicines must be a Priority As the general election gathered momentum, the Irish Pharmaceutical Healthcare Association (IPHA) has urged all political parties to pledge to improve patients’ access to new medicines as part of their plans for health. Ireland remains among the slowest in Western Europe to provide new medicines to patients. In the last Dáil, we saw patients groups regularly having to protest for access to new medicines. Ministers ended up making political decisions on medicines. At the same time, very large savings, price cuts and cash rebates are still being provided by pharmaceutical companies to the HSE.
should adopt an explicit policy on how to allocate funding to new medicines, relying on both the State and industry contributions.
are convinced this can be fixed. It needs political will to work out a better way with the industry for reimbursing new medicines.
“As the political parties finalise their policy proposals ahead of the February 8th poll, we would urge them to place improving patients’ access to new medicines at the core of their plans for health,” said Mr O’Connor.
Oliver O’Connor, the Chief Executive of IPHA, said the industry is clear that there is a better way possible.
Irish patients are waiting up to three times longer for the same medicines patients in other European countries can get.
"Budget 2020 allocated no new funding for new medicines. This will not be sustainable. It will not deliver new medicines on time for patients. The reliance on industry and HSE internal savings alone to fund new medicines will run out of road. The HSE has to take care of a growing and ageing population, absorbing a substantial part of its additional funds.
“First, political parties should pledge to improve patients’ access to new medicines and assure them that protesting for medicines will be a thing of the past.
“That means doctors have fewer options for treatments than in other countries. That must affect standards of care in Ireland. It means the latest treatments are often beyond the reach of patients and their doctors. We
“Second, the next Government
"The way forward is political backing by parties and the next Government for serious discussion on funding new medicines between central Government, the HSE and the industry,” said Mr O’Connor. “This can be achieved in time for Budget 2021."
“The way forward is political backing by parties and the next Government for serious discussion on funding new medicines between central Government, the HSE and the industry. This can be achieved in time for Budget 2021”
Sergios’s Research on Display Sergio Martin, Supervising Pharmacist with St James Late Night Pharmacy who recently attended, and had a poster presentation on display of his research project regarding dispensing errors in community pharmacy in Ireland. Sergio presented at the Prescribing in Research and Medicines Management (PRIMM) Annual Scientific Meeting. PRIMM presents an opportunity for multi-disciplinary practitioners and researchers involved in medicines management and optimisation practice, quality improvement and research to network, share and learn. Sergio Martin, Supervising Pharmacist with St James Late Night Pharmacy
Pharmacy Reminder on Methadone Reminder: Inspectors Advice on Balance Checks and Reconcilation of Methadone Products Pharmacists should conduct regular balance checks to verify that the balance recorded in the controlled drugs register accurately reflects the volume of Methadone liquid present at the pharmacy. The Pharmaceutical Society of Ireland is reminding pharmacists of this article outlining their obligations in relation to balance checks and reconciliation for Methadone products. Pharmacists should be aware that a manufacturer’s bottles of methadone liquid contain a small ‘overage’ in some cases. The extra liquid can result in a pharmacy having more Methadone than expected in certain circumstances. The purpose of this piece is to remind pharmacists to carry out their balance checks in regard to Methadone. • The frequency with which the CD register is reviewed should be determined by the Supervising Pharmacist. This may vary from pharmacy to pharmacy and will depend on the frequency of methadone dispensing, the volume of methadone dispensing, previous stock balance discrepancies etc. • To carry out a balance check, it is necessary for pharmacists to calculate the total volume of each Methadone product which is physically present at the pharmacy, including: a) The total volume of the full bottles of each Methadone product, and b) The total volume of open bottles of each Methadone product (a pharmacist is required to measure the actual volume of liquid contained in each open bottle of Methadone liquid using a graduated cylinder). The total volume of Methadone liquid for each product (closed bottles plus open bottles) should then be compared against the balance recorded in the CD register for this product.
To Relieve ANY Cough 1
For children from 1 year Associated with a cold.
2020 To Do List 1. Take on a PURE PHARMACY franchise. 2. Go Vegan???
PURE have 2 options available; 1. For those who already own a pharmacy and wish to grow it using the PURE brand. 2. For those who want to take the step towards owning their own pharmacy.
Professional Development at the Heart of Stacks Continuing Professional Development (CPD) for the community pharmacy profession is a continual process of lifelong learning. It follows the four-stage cycle of reflection, planning, action and evaluation. CPD offers an opportunity to registrants to reflect on their current practice and to anticipate and respond to changing demands. It enables them to keep up to date and fit to practise, and to maintain the professional standards required for registration throughout their professional career. With this in mind, Stacks Pharmacy Group kick-started 2020 with a gathering of 33 of their pharmacists for a CPD training day, which was held in the Leixlip Manor Hotel in early January. The day was filled with informative sessions covering various topics. At the Heart of Communities Brian Battles, Dispensary Operations Manager for the Group and organiser of the day, told Irish Pharmacy News, “Stacks’ Pharmacists are passionate about the wellbeing of each patient we care for in our eighteen pharmacies across eight counties. This care and dedication are at the heart of the family feel community pharmacy created by Ade Stack from her first pharmacy in Skerries since 2000.” While this was a Pharmacist CPD day, Ade together with the Stacks management team are always conscious that behind every excellent pharmacist are great dispensary and OTC teams.
Stacks Pharmacy Group CPD Training
Confirmation of this is the fact that Ade’s first employee in Bernie is still an integral part of the team in Skerries, with many other Pharmacists, Technicians and OTC staff working with Stacks for over ten years! The CPD system for pharmacists in Ireland provides for formal recognition and evidence of professional development whilst also assuring the public of the competence of pharmacists. It is peer-led, peer supported and peer-assessed. According to the Pharmaceutical Society of Ireland, it should ‘support, in time, the recognition of specialisation and advanced practice roles.’ The system should assist in the development of pharmacy practice in order to meet evolving evidence-based patient and health service needs. The CPD system should also aim to enhance interprofessional learning and collaboration.
Ade Stack, Pharmacist and MD, Stacks Pharmacy Group
The Stacks Pharmacy CPD Training day began with Brian welcoming everyone, thanking those who had supported the day and outlining what was instore for the day, and what a line up it was. First the group heard from Sinead Murray, Antimicrobial Pharmacist and Chief 2 Pharmacist at St Vincent’s Private Hospital. Sinead delivered a insightful eye opening presentation on antimicrobials highlighting the harsh reality facing some patients in our hospitals across the country who are finding themselves resistant to all available antimicrobials.
Brian Battles, Dispensary Operations Manager, Stacks Pharmacy Group
Siobhan Hollinhsworth, Clinical Nurse Specialist, Registered Nurse Prescriber Palliative Care
Professional Development at the Heart of Stacks Delegates then heard from Siobhan Hollingsworth, Clinical Nurse Specialist/Registered Nurse Prescriber Palliative Care. Siobhan has worked for many years in palliative care in the hospital setting but for the past number of years has been providing palliative care in the home across Wicklow. Paraic Kilcoyne together with Ade, introduced a recently developed technician training checklist tool to the group. The checklist has been developed between Mark Keegan within Human Resources, Brian and a number of technicians across the group.
Audrey Dunne Supervising Pharmacist Castledermot Branch
Rachel Dungan, Pharmacist and MD, 4Front Pharmacy
First up in the afternoon was Rachel Dungan from 4Froint Pharmacy with her presentation on ‘Leveraging your impact as a pharmacy leader. Rachel also gave an informative introduction to 4Front online pharmacy training.
Ade finished the day with a recap from the day reinforcing the key messages from the keynote speakers. Clare Grehan Supervising Pharmacist Marley Park Pharmacy commented following the event, “Pharmacies can be busy stressful places. Good time and team management and are paramount in getting through the workload. Normally I would focus on clinical areas when doing CPD at home so I found the Personal Leadership Module very helpful and am applying the principles we learned at work now at the start of each day.”
Commencing in February 2020 Stacks pharmacy will roll out 4Front OTC training across its eighteen pharmacies.
“Today was a great chance to interact with pharmacists from other branches and both voice and listen to opinions on a range of
Audrey Dunne a Stacks Pharmacist in Castledermot, Co. Kildare then talked the group through the journey that was her Diploma in Community Pharmacy from Trinity College last year while working full time. Audrey was named in the top 100 dynamic people in community pharmacy 2019.
“The CPD Day was an excellent opportunity to engage with all the other pharmacists in our company, get to meet some of the new employees and catch up with familiar faces. We had very engaging lectures from leading professionals in the healthcare system that were informative, thoughtprovoking and from which many points could be taken away and applied to our own practice”
Paraic Kilcoyne Supervising Pharmacist Limerick Branch
topics. I also found the speakers on the day to be very informative and approachable,” added Graham Claxton, Supervising Pharmacist with the Stacks Pharmacy Swords Branch. Kevin Feely isSupervising Pharmacist with Stacks Pharmacy Ratoath Branch and added “I have to say I found the day very beneficial. Firstly it gave us all a chance to meet each other and put a face to the name. I enjoyed hearing from the speakers especially getting to hear pharmacist working in different practice area and their outlook on things. I found the day allowed us to get re focused on our roles in store by giving us small project to enact in store.”
“This event provided a great opportunity for our pharmacists to get together and develop our knowledge in specific areas. It allows us to bring back new up to date information to our teams and improve our overall services for our patients”
Cosmetic & Gift Trade Fair
2020 The Main Hall, RDS, Ballsbridge, Dublin Sunday 17 th May
10am - 6pm
Monday 18 th May
9am - 8pm
Tuesday 19 th May 9am - 6pm
Pharmacy on Political Manifesto Campaigning was well underway for Ireland’s 2020 Election as IPN went to press. On 8 February, for the first time since Irish independence, voters went to the polls on a Saturday. We take a look at what is contained pertinent to pharmacy and health in the key political party 2020 Manifesto’s. Fine Gael Fine Gael say their plan delivers an increase to current health funding of ¤5 billion over the next five years. With specific mention to pharmacy they state, “We will also begin talks this year with our pharmacists on a new contract and enhance the role of pharmacists in the delivery of healthcare.” They also state that they will establish a National Medicines Agency, promoting national prescribing to reduce the cost of medicines, to set a fair price for drug reimbursement and to speed up the reimbursement of new drugs, including those for rare diseases. “We are implementing a National Biosimilars Policy to help patients to access cheaper medicines. Fine Gael in Government delivered the last Framework Agreement on the Supply and Pricing of Medicines in 2016 and will deliver a new one in 2020,” they say.
They are also claiming to deliver free GP care for under 18s among other measures to reduce the cost of care; further reduce prescription charges and reduce the Drug Payment Scheme to a maximum of ¤75 a month. Fianna Fáil “Community pharmacists are keen to play a greater role in healthcare in Ireland. Pharmacists in other countries routinely offer a wider range of vaccination and other medical services. We need to expand their remit. We will negotiate a new contract with pharmacists and expand their role,” says the party.
contract and to expand the role of community pharmacists. They also state they will abolish prescription charges and roll-out free prescription medicines for all at, a cost of ¤330 million. Sinn Féin also want to see a state-sponsored contraception scheme for women. Labour
Labour say they will train more GPs and invest in practices, so that every community has access to a doctor. Labour will expand the role of advanced nurse practitioners, physician associates and community pharmacists, to help fill the gap while additional GPs are being recruited. We will end the two-tier pay system for nurses and other medical professionals. Labour will redirect funding to local primary care centres closer to communities, which will provide medical tests, disability supports, mental health services and help people to manage long-term disease like diabetes.
In their ‘Manifesto for Change’, Sinn Féin make clear their intention to also commence negotiations on a new pharmacy
They will extend free-of-charge GP care to all under-18s, and to everyone with a long-term illness or disability.
They also state they will reduce the Drug Payment scheme threshold to ¤100 (at a cost of ¤14.3m); Reduce the Drugs Payment Scheme threshold for single households to ¤72 (at a cost of ¤8.3m), and; Abolish prescription charges (at a cost of ¤68m).
“We will also begin talks this year with our pharmacists on a new contract and enhance the role of pharmacists in the delivery of healthcare” – Fine Gael “Pharmacists in other countries routinely offer a wider range of vaccination and other medical services. We need to expand their remit. We will negotiate a new contract with pharmacists and expand their role” – Fianna Fail
“We will commence negotiations on a new pharmacy contract and to expand the role of community pharmacists” – Sinn Féin
“Labour will expand the role of advanced nurse practitioners, physician associates and community pharmacists, to help fill the gap while additional GPs are being recruited” – Labour
Critical Results in Community The Health & Safety Executive (HSE) and Royal College of Physicians of Ireland (RCPI) have launched a new guideline for communicating critical lab results to patients. The new guideline, launched by HSE CEO, Paul Reid, sets out the agreed approach and timelines for communicating results to patients in the community based on the severity of potential underlying diagnoses, imminent risk to the patient and the urgency of intervention. Results are categorised as follows: Category A - results require communication within two hours as they indicate potential immediate danger to the patient, or a potentially life-threatening illness when urgent intervention is required Category B - results require communication within 24 hours, preferably on the same working day Category - C results can be communicated the next working day as they may have an immediate impact on a patient’s management (either treatment or investigation). Mr Reid said, “The guideline is a welcome patient safety initiative providing clear information for both staff working in laboratories and health care staff who request tests such as GPs and nursing staff for communicating critical laboratory results. It will help to ensure that patients who have a lab test result indicating they require urgent treatment, are contacted in a timely manner and arrangements put on place to make sure they promptly receive the treatment they require.” The guideline has been developed in consultation with all pathology disciplines, nursing, the hospital groups, hospital based and community laboratory users, GPs, patient representatives, the Traffic Medicine Programme, National Emergency Operations Centre (NEOC) and National Ambulance Service. “In the event the requester of the lab test is not contactable, the guideline outlines a clearly defined process for contacting the patient, and arranging their care in the local Emergency Department,” said Dr Mary Keogan, Clinical Lead Pathology Programme.
AVAILABLE NOW NOW AVAILABLE
¦ ¦ ¡ §¢ ¤ ¡ §¢ ¤ ¢ ¢ ¢ ¢
Shortages in Pharmacy continue to Spiral Medicines shortages in community pharmacy continues to get worse, results from a recent survey have shown. Darragh O’Loughlin, General Secretary of the Irish Pharmacy Union
The unavailability of medicines is on the rise in Europe and it has a tremendous impact on patients. Medicine shortages occur across all healthcare settings and involve both essential life-saving medicines and very commonly used drugs.
"Not only is this putting their health at risk but it is causing undue stress, fear and anxiety for patients"
financial burden but also a loss of opportunity to spend time with other patient-centred tasks and to improve the quality of care.
patients' ability to manage their illness and leaving pharmacists scrambling for essential supplies, a Kerry pharmacist says.
Today, community pharmacists still manage to ensure continuity of care and minimise the impact on their patients’ health status in most cases. However, several barriers should be removed to further support community pharmacists in this key role, considering that the impact on practice is increasing every day.
Each year, the Pharmaceutical Group of the European Union conducts a survey among its membership to map the impact of medicine shortages across Europe from the community pharmacists’ perspective.
Community pharmacists are very concerned about this phenomenon, which can compromise patients’ health. Moreover, pharmacies and pharmacists invest a lot of Pharmaceutical Group of European Union resources dealing with shortages Groupement Pharmaceutique de l’Union Européenne which constitutes not only a Drug shortages are affecting
Darragh O’Loughlin, General Secretary of the Irish Pharmacy Union says, “The release of this survey underlines that medicine
5. In your opinion, how have medicines shortages adversely affected patients in your country? Tick all that apply (% of responding countries) 100%
80% 70% 60% 50% 40% 30% 20% 10% Caused Increased co- Interruption of Medication distress and payments treatments errors inconvenience (14/24) (18/24) (6/24) (24/24)
Adverse Sub-optimal treatment/ events/greater toxicity inferior (4/24) efficacy (10/24)
Other (please specify) (4/24)
The 2019 survey shows that in the past 12 months, and the vast majority (87%) of respondents indicated that the situation got worse compared to 2018 and that all classes of medicines are affected by medicine shortages in community pharmacies. The 2019 PGEU Medicine Shortages Survey Results cover the responses from 24 European countries. In the majority of responding countries (67%), over 200 medicines were listed as in short supply at the time of completing the survey. All responding countries indicated that they believe medicine shortages cause distress and inconvenience to patients. Interruption of treatments (75% of countries), increased co-payments as a result of more expensive/ non-reimbursed alternatives (58%) and suboptimal treatment/inferior efficacy (42%) are also perceived as negative consequences of medicine shortages on patients.
shortages are an increasing challenge not just in Ireland but across Europe. In Ireland, we have experienced significant shortages of medicines in the last year and the situation continues to get worse. Patients can sometimes wait for weeks to get a new supply of a common drug. Not only is this putting their health at risk but it is causing undue stress, fear and anxiety for patients. Instead of directing their efforts and professional expertise towards the needs of patients, pharmacists are spending nearly 7 hours a week resolving medicines shortages and firefighting on behalf of our patients. While medicine shortages are an ongoing problem, patients should be reassured that pharmacists make every effort to ensure that their patients receive the medicines they need.”
Belgium: It is hard to prove or measure what the consequences of actual shortages have been in
Medicine shortages are believed to affect community pharmacy businesses in most countries by reduced patient trust (92% of countries), financial loss due to time invested in mitigating shortages (82%) and reduced employee satisfaction (79%). Across European countries, strong differences exist in terms
(fluticasone furoate/umeclidinium/vilanterol) The only COPD Triple Therapy delivered in a single daily inhalation.1 Improvement in quality of life vs. ICS/LABA.2,3
LESS TO TAKE. MORE TO TAKE IN. A combination of ICS/LAMA/LABA (FF/UMEC/VI) administered through a single daily inhalation from the Ellipta inhaler, which is easy to use1-5 ▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. TRELEGY Ellipta FF/UMEC/VI 92/55/22 mcg OD is indicated for Maintenance treatment in adult patients with moderate to severe COPD who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) or a combination of a LABA and a long acting muscarinic antagonist. COPD, chronic obstructive pulmonary disease; FF, fluticasone furoate; ICS, inhaled corticosteroids; LABA, long-acting β2-agonist; LAMA, longacting muscarinic antagonist; OD, once-daily; UMEC, umeclidinium, VI, vilanterol. References: 1. TRELEGY Ellipta SmPC, available at www.medicines. ie, last accessed October 2019. 2. Lipson DA et al. Am J Respir Crit Care Med 2017; 196:438–446. 3. Lipson DA, et al. N Engl J Med. May 3 2018;378(18):1671-1680. 4. Svedsater H et al. BMC Pulm Med 2013; 13:72–86. 5. van der Palen J et al. NPJ Prim Care Respir Med 2016; 26:16079. Trelegy▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol [as trifenatate]) Prescribing information. Please consult the full Summary of Product Characteristics (SmPC) before prescribing. Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol [as trifenatate]) inhalation powder. Each single inhalation of fluticasone furoate (FF) 100 micrograms (mcg), umeclidinium bromide (UMEC) 62.5
micrograms and vilanterol as trifenatate (VI) 25 mcg provides a delivered dose of 92 mcg FF, 55 mcg UMEC and 22 mcg VI. Indications: Maintenance treatment in adult patients with moderate to severe COPD who are not adequately treated by a combination of an inhaled corticosteroid (ICS) and a long-acting β2-agonist (LABA) or a combination of a LABA and a long acting muscarinic antagonist. Dosage and administration: One inhalation once daily at the same time each day. Contraindications: Hypersensitivity to the active substances or to any of the excipients (lactose monohydrate & magnesium stearate). Precautions: Paradoxical bronchospasm, unstable or life-threatening cardiovascular disease or heart rhythm abnormalities, convulsive disorders or thyrotoxicosis, pulmonary tuberculosis or patients with chronic or untreated infections, narrow-angle glaucoma, urinary retention, hypokalaemia, patients predisposed to low levels of serum potassium, diabetes mellitus. In patients with moderate to severe hepatic impairment patients should be monitored for systemic corticosteroid-related adverse reactions. Eye symptoms such as blurred vision may be due to underlying serious conditions such as cataract, glaucoma or central serous chorioretinopathy (CSCR); consider referral to ophthalmologist. Increased incidence of pneumonia has been observed in patients with COPD receiving inhaled corticosteroids. Risk factors for pneumonia include: current smokers, old age, patients with a history of prior pneumonia, patients with a low body mass index and severe COPD. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take Trelegy. Acute symptoms: Not for acute symptoms, use short-acting inhaled bronchodilator. Warn patients to seek medical advice if short-acting inhaled bronchodilator use increases. Therapy should not be abruptly stopped without physician supervision
due to risk of symptom recurrence. Systemic effects: Systemic effects of ICSs may occur, particularly at high doses for long periods, but much less likely than with oral corticosteroids. Interactions with other medicinal products: Caution should be exercised with concurrent use of β-blockers. Caution is advised when co-administering with strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir, cobicistat-containing products), hypokalaemic treatments or non-potassium-sparing diuretics. Co-administration with other long-acting muscarinic antagonists or long acting β2-adrenergic agonists is not recommended. Pregnancy and breast-feeding: Experience limited. Balance risks against benefits. Side effects: Common (≥1/100 to <1/10): pneumonia, upper respiratory tract infection, bronchitis, pharyngitis, rhinitis, sinusitis, influenza, nasopharyngitis, candidiasis of mouth and throat, urinary tract infection, headache, cough, oropharyngeal pain, arthralgia, back pain. Uncommon (≥1/1,000 to <1/100): viral respiratory tract infection, supraventricular tachyarrhythmia, tachycardia, atrial fibrillation, dysphonia, dry mouth, fractures; Not known (cannot be estimated from the available data): vision blurred. Marketing Authorisation (MA) Holder: GlaxoSmithKline Trading Services Limited, Curabinny, Co. Cork, Ireland. MA No. [EU/1/17/1236/002]. Legal category: POM B. Last date of revision: June 2019. Code: PI-2093. Further information available on request from GlaxoSmithKline, 12 Riverwalk, Citywest Business Campus, Dublin 24. Tel: 01-4955000.
Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at www.hpra.ie. Adverse reactions can also be reported to the HPRA by calling: (01) 6764971. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255. A full list of adverse reactions can be found in the Summary of Product Characteristics. In common with other corticosteroid-containing medicines, there is an increased risk of pneumonia in patients with COPD treated with TRELEGY Ellipta.1 Trelegy Ellipta should be used with caution in patients with unstable life-threatening cardiovascular disease.1
Please see www.trelegy.ie to find out more
TRELEGY Ellipta was developed in collaboration with TRELEGY and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies. © 2019 GlaxoSmithKline Group of Companies. All rights reserved. PM-I E-FVU-ADVT-190002 Date of preparation: October 2019
PGEU GPUE 16
Pharmaceutical Group of European Union Groupement Pharmaceutique de l’Union Européenne
6. In your opinion, how have medicines shortages affected community pharmacies in your country? Tick all that apply (% of responding countries)
The Health Products Regulatory Authority has been notified of a shortage of the following products:
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0%
Ireland Shortages 2020
Financial loss due to Direct financial loss Financial loss due to Reduced Reduced employee time invested in due to increased needed operational patient/customer satisfaction mitigating sourcing prices as a changes such as trust (19/24) shortages reaction to low minimum stock (22/24) (20/24) availability of a keeping, import certain medicine fees etc. (9/24) (13/24)
Other: please describe (2/24)
7. Which solutions can legally be offered by pharmacists in case of a shortage?2
of legal Tick solutions community 25% of responding all that apply (% of responding countries)countries pharmacists can offer in case of indicated that there is still no a100% shortage. Generic substitution reporting system for shortages (79 % of countries), sourcing the in place which can be used by 90% same medicine from alternative community pharmacists in their 80% authorised sources (such as other country, despite that pharmacists pharmacies) (63%), and importing often experience or foresee supply 70% the medicine from a country difficulties before the industry or 60% where it is available (46%) are the wholesalers are aware that there 50% solutions which can be provided is, or will be, a problem. in most of the European countries. 40% Community pharmacists receive Furthermore, the time pharmacy the needed information on 30% staff has to spent on dealing with shortages in most countries from 20% medicine shortages has increased wholesalers (71%), medicines 10%5,6 hours per week (2018) to from agencies (67%) and pharmacy 6,6 hours per week on average. organisations (42%). 0%
In response, a spokeswoman for the HPRA said medicine shortages have become increasingly prevalent worldwide over the past decade. The causes are multi-factorial, including shortages of raw materials, manufacturing difficulties, product recalls due to potential quality defects, industry consolidations and the parallel trade of medicines to other markets.
Sourcing the same Changing to the Generic substitution Therapeutic medicine from same medicine with (19/24) substitution alternative a different strength (6/24) authorised source (10/24) Daly's Pharmacy has been caring for the people of Naas (15/24)
Importing the medicine from another country (11/24)
Daly’s Pharmacy offer Naas Defribillator
for over a hundred years, and is delighted to continue that tradition by announcing the installation of 2 a Public Access Defibrillator on their shop front. Importing the medicine from another country: the authorisation to import a foreign medicinal product with the same composition than the affected medicinal product in exceptional circumstances. This can include the approval Thérèse Lawlor, owner of Daly's of the exemption to certain labelling and package leaflet obligations. Pharmacy, says, "It is the only
defibrillator publicly available Rue du Luxembourg 19, 1000 Brussels, Belgium | Phone: +32 2 238 08 18 | A.I.S.B.L. | BEStreet, 0468.971.838 on the Main in such a prominent location close to shops, firstname.lastname@example.org | www.pgeu.eu businesses and schools, right in the heart of our town. We at Daly's Pharmacy are proud to invest in this life saving technology for the benefit of all people who live in and visit Naas." Five thousand people a year in Ireland die from sudden cardiac arrest. 70% of these occur out of hospital. If a defibrillator is used and CPR is performed within five minutes of cardiac arrest, survival chances increase from 6% to 74%. Julie Banim Naas Community First Responders, Dervla Hynes Pharmacist, Cllr Bill Clear Naas Municipal District, Thérèse Lawlor Owner Daly's Pharmacy, Amanda Ross Naas Community First Responders and Janet Ward Beauty Consultant Daly's Pharmacy
• Amisulpride 50mg Tablet – PA0577/182/001 • Amisulpride 200mg Tablet – PA0577/182/002 • Amoxil 500mg Powder for Solution for Injection or Infusion – PA1077/033/004 • Azithromycin Teva 250mg Film Coated Tablet – PA0749/039/002 • Cordarone X Intravenous 150mg/3ml Concentrate for Solution for Infusion or Slow Injection – PA0540/142/003 • Gerozac 20mg Capsule – PA0577/200/001 • Gerozac 60mg Capsule – PA0577/071/001 • Olmesartan Medoxomil Clonmel 10mg Film Coated Tablet – PA0126/273/001 • Pabrinex Intraveneous High Potency Concentrate for Solution for Infusion – PA2288/001/001 • Ultiva 2mg Powder for Concentrate for Solution for Infusion – PA1691/032/002 • Valsartan Mylan 320mg Tablet – PA0577/134/004 • Zithromax 250mg Capsule (6 pack presentation only) – PA0822/191/001 The following shortage has been resolved and supply has resumed to the Irish market: • Arcoxia 120mg Film Coated Tablet – PA1997/001/004 • Cozaar 50mg Film Coated Tablet – PA1286/004/002 • Efexor XL 37.5mg Prolonged Release Capsule – PA0822/072/001 • Epanutin 30mg/5ml Oral Suspension – PA0822/011/007 • Estradot 50mcg Transdermal Patch – PA0896/010/002 • Glypressin 1mg Powder and Solvent for Solution for Injection – PA1009/004/001 • Lecalpin 20mg Tablet – PA2315/186/002 • Menopur 600IU Powder and Solvent for Solution for Injection – PA1009/015/002 • Mivacron 2mg/ml Solution for Injection – PA1691/033/001 • Ondansetron 4mg Tablet – PA0749/009/001 • Septrin 80mg/400mg Tablet – PA1691/010/001 • Valsartan Hydrochlorothiazide Teva 80mg/12.5mg Tablet PA0749/047/001
HEADACHE PANADOL EXTRA SOLUBLE RELIEVES 5 TYPES OF TOUGH PAIN
Headaches Period pain Joint pain
Back pain Dental pain
Panadol Extra Soluble has a dual active formula which provides up to 30% more powerful pain relief than standard paracetamol.1
RECOMMEND PANADOL EXTRA SOLUBLE for fast pain relief
Reference. 1. Laska EM et al. JAMA. 1984; 251(13):1711-1718.
Panadol Extra 500mg/65mg Soluble Effervescent Tablets. Contain paracetamol. Always read the label/leaflet. Product Information: Please consult the summary of product characteristics for full product information. Panadol Extra 500mg/65mg Soluble Effervescent Tablets, paracetamol 500mg, caffeine 65mg. Indications: Relief of mild to moderate pain including rheumatism, neuralgia, musculoskeletal disorders, headache, symptoms of colds and flu, fever, toothache and menstrual pain. Dosage: Adults and children 16 years and over: 2 tablets up to 4 times a day. Do not exceed 8 tablets in 24 hours. Children aged 12-15 years: 1 tablet up to 4 times a day. Do not exceed 4Â tablets in 24 hours. Do not give to children under 12 years. Minimum dosing interval: 4 hours. Contraindications: Hypersensitivity to paracetamol, caffeine or any ingredients. Precautions: Avoid concurrent use with other paracetamol-containing products. Diagnosed liver of kidney impairment. Patients with depleted glutathione levels or chronic alcoholism or sepsis. Avoid excessive caffeine intake. Caution in those with hereditary sugar intolerance or on a low sodium diet. Should not be used in pregnancy or lactation without medical advice. Do not exceed the stated dose. Prolonged use except under medical supervision may be harmful. Side effects: See SPC for full details. All very rare: Thrombocytopenia, hypersensitivity reactions including anaphylaxis and skin rash, angioedema, Stevens-Johnson syndrome, bronchospasm, hepatic dysfunction. Frequency unknown: Nervousness, dizziness. When combined with dietary caffeine intake, higher doses of caffeine may increase potential for caffeine related adverse events such as insomnia, restlessness, anxiety, irritability, headaches, GI disturbances and palpitations. Overdose: Immediate medical advice should be sought in the event of an overdose, even if symptoms of overdose are not present. Legal Category: Supply through pharmacy only. MA Number: PAÂ 678/39/10. MA Holder: GlaxoSmithKline Consumer Healthcare (Ireland) Limited, 12 Riverwalk, Citywest Business Campus, Dublin 24. Additional information is available upon request. Text prepared: November 2019. CHGBI/CHPAN/0107/19
Pharmacy must be empowered with Vaccines The role of pharmacists in immunisation and vaccination varies across the world; in some countries pharmacists are primarily involved in ensuring the safe supply and dispensing of vaccines, as well as advocating for immunisation, while in other countries they are empowered to play a more active role, as they are legally authorised organise vaccinations activities and campaigns.
It is estimated that ten million lives per year could be saved by increasing access to medicines and vaccinations. Community pharmacists are therefore in a strong position to provide a major contribution to public health due to their accessibility, distribution and available medicines expertise. Pharmacists are also highly trusted healthcare professionals and can therefore significantly improve communication channels and provide public reassurance on product quality.
Meningococcal disease is caused by infection with Neisseria meningitidis and presents as bacterial meningitis (15 per cent of cases), septicaemia (25 per cent of cases), or a combination of the two. It is the leading infective cause of death in early childhood. There are several strains or â€˜groupsâ€™ of meningococcal bacteria (A, B, C, W, X and Y). In the past 50 years, most
meningococcal disease in the UK and Ireland2has been due to group B (MenB) and group C (MenC), although the MenC vaccine introduced in 1999 has now successfully reduced cases to just a handful each year. Currently MenB accounts for the vast majority of meningococcal disease although we have recently seen an alarming rise in a particularly deadly strain of meningococcal W meningitis and septicaemia.
There are five main groups that commonly cause disease - MenA, MenB, MenC, MenW, MenY. MenB causes the majority of the disease. How it is caused: â€˘ Around 10% of the population carries meningococcal bacteria in the back of their throats at any given time. This is usually healthy carriage and helps develop immunity
inthe theongoing ongoingbattle battleagainst against serious serious childhood childhood diseases. diseases. in
• Occasionally the bacteria defeat the body’s defences and cause infection • The bacteria are passed from person to person by coughing, sneezing and intimate kissing • The bacteria break through the lining at the back of the throat and pass into the bloodstream • They can travel in the bloodstream to infect the meninges, causing meningitis, or while in the bloodstream they can cause septicaemia From September last year, secondary school children in first-year are offered a meningococcal ACWY booster vaccination. This is being rolledout this month (February). The Meningococcal ACWY vaccine will boost children’s protection against group C meningococcal disease. It will also provide additional protection against meningococcal groups A, W and Y. In addition, this vaccine also reduces the risk of carrying the disease so can help protect other people too. MenACWY being used in Ireland is Nimenrix. This is a conjugate vaccine containing Group A, C, W and Y polysaccharides conjugated to tetanus toxoid carrier protein. The vaccine protects against N. meningitidis Groups A, C, W and Y invasive disease.
Immunisation Advisory Committee (NIAC) recommended that one dose of MenACWY vaccine should be given to all students in 1st year of second level education replacing the MenC vaccine in 2019. Meningococcal disease can start very suddenly. Symptoms include fever, stiff neck, headache, joint pains and a rash. Meningococcal disease can occur at any age, but the highest rate occurs in children under 5 years of age, especially children under 1 year old. The next high-risk group are young people aged 15-19 years. Importantly for community pharmacists to be aware, they might have school children and/ or their parents presenting to the pharmacy with associated after effects. Some students can have an area of soreness, swelling and redness in their arm where the injection was given. This usually passes after a day or two. Some students may get a headache, feel sick in their tummy or run a slight temperature. If this happens, paracetamol or ibuprofen will help. Vaccine Alliance Last year, a new Vaccine Alliance was launched, aimed
Since 2015 more cases of invasive meningococcal serogroups W and Y disease have been seen in Ireland. Prior to 2015 the annual number of both serogroups was low. Between 1999 and 2014 there was an average of two cases for both serogroups reported per year. Between 2015 and 2018, a total of 36 serogroup W and 20 serogroup Y cases were reported, giving an average annual notification rate 9 cases per year of serogroup W and for 5 cases per year of serogroup Y. In view of the emergence of meningococcal serogroups W and Y, the National
at boosting the uptake of childhood vaccines and reducing vaccine hesitancy. The Alliance will include healthcare professionals, policy makers, patient advocates, students, and representatives from groups most affected by vaccine hesitancy. A Steering Group to guide the work of the Vaccine Alliance has already met and includes a wide range of organisations including Barnardos, Unicef Ireland, Science Foundation Ireland, Pavee Point, and the Union of Students of Ireland, as well as parents, doctors, nurses, midwives and pharmacists. Further organisations will be added once the vision, values and aims of the Alliance have been agreed. The Alliance was launched by Minister for Health Simon Harris TD who said, “Vaccination rates across the country are falling and diseases we had consigned to the history books are now making a comeback. We cannot afford to do nothing. We cannot allow the success of our childhood immunisation programme become its enemy. “This Alliance will build on the success we have had with the HPV vaccine where rates increased from 51% to 70% in a short period of time and it will ensure parents have accurate, evidence-based information about vaccinations.”
Ireland Allergy Crisis One of the country’s leading allergy experts has called for a complete overhaul of the State’s response to Ireland’s hidden allergy health crisis. Professor Jonathan Hourihane, a Professor of Paediatrics in the Royal College of Surgeons in Ireland and a Consultant Paediatrician in the Children’s Hospital at Temple St, said with allergy rates rising — about 24% of Irish people suffer from some form of allergy: 40,000 alone are allergic to nuts — the State's existing policy response is “wrapped up in red-tape” and must be streamlined. Whether patients are coping with allergies caused by seasonal, non-seasonal, or food allergens, pharmacists can help patients prevent and manage their bothersome symptoms. It is believed there are 250 children on waiting lists in Cork alone to see an allergy specialist, some waiting up to four years for an appointment. Professor Hourihane says investment in the front-line medical response to a condition which in some cases can be fatal must be ramped up. “These are community diseases. Allergies are more common than diabetes, epilepsy, or Parkinsons but they can be looked after by family doctors and local clinics,” he said. He was speaking just as a new TG4 documentary was aired which shone a light on the work of experts at Cork University Hospital's (CUH) Allergy Clinic. Ailléirgí by Midas Productions investigated the reasons behind a steep rise in allergies suffered by Irish people over the last two decades. Twenty years ago the number of those with allergies stood at just 1%. This is an area that pharmacists are well placed to identify. Selfreporting of allergy is common, with some patients already having an allergy diagnosis. It is important for pharmacists to consider whether management in the pharmacy is appropriate, to acknowledge expertise limitations and know when to direct a patient to their GP. Professor Jonathan Hourihane RCSI
Elements, our best in class unlicensed medicine sourcing solution
Why? LIST ON REQUEST
All products listed on request.
We are continuously growing our product range, in 2019 we expanded our portfolio by 30%.
Delivery schedule in line with United Drug deliveries - We deliver up to 6 days a week.
Turnaround time as low as 48 hours for emergency orders.
We proactively source an unlicensed alternative where available as soon as a licensed product become unavailable to the market.
For ease of ordering visit www.udw.ie or contact our customer care team for queries on 01-4632410
Advising on Bladder Weakness and Incontinence
ncontinence is a condition that most people are too embarrassed to talk about, yet one that affects one in three women and one in nine men, and costs the HSE â‚Ź100 million every year.
Urinary Incontinence (UI) can have a hugely negative impact on a personâ€™s quality of life, mood and confidence with some sufferers becoming virtual prisoners in their own homes. The market for incontinence products is rapidly growing as the issue slowly becomes more recognised and sufferers start to seek help. According to Euromonitor, in recent years, adult male incontinence became increasingly recognised as a significant problem in Ireland. As a result, light incontinence benefited,
and will continue to do so over the forecast period. Despite the dominance of the leaders, the changing nature of the marketplace has seen other brands begin to win share. As male incontinence becomes a more significant part of the category, private label players have begun to win share by introducing new product developments specifically tailored to male incontinence, such as swimming and gym pants. Interestingly, Ireland has one of the highest ownership rates for smartphones in the EU, and
22 | PHARMACYNEWSIRELAND.COM
according Ecommerce.eu Irish consumers are the second highest average spenders per annum online in the EU. Prevalence Prevalence increases with age, with an estimated 46% of women and 34% of men aged 80-plus affected. Whatâ€™s more concerning is that up to 80% of sufferers have never sought medical advice and 35% view it as simply part of the ageing process. In most cases these conditions can be easily treated or significantly improved via straightforward interventions.
The local pharmacy has the advantage of being a familiar environment but one with experienced and specially trained staff whom customers trust. Types of Incontinence Urinary incontinence is loss of control of the bladder. It can affect anyone, regardless of age. It is a condition which ranges from mild to uncontrollable and embarrassing wetting. Incontinence can often be caused by an illness, such as a urinary tract infection, and often when the infection gets better the incontinence improves.
TREATS HEARTBURN AND ACID REFLUX. ONE TABLET PER DAY. LASTS 24 HOURS. AVAILABLE IN PACKS OF 7s AND 14s. Marketed by
CCF:22656 Date of preparation: (10-19)
ABBREVIATED PRESCRIBING INFORMATION Product Name: Emazole Control 20 mg Gastro-Resistant Tablets Composition: Each tablet contains 20 mg esomeprazole (as magnesium dihydrate). Description: Light pink oval film coated tablet. Indication(s): Proton Pump Inhibitor (PPI): Short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults. Dosage: Swallow tablets whole with liquid, do not chew or crush. Disperse in half a glass of non-carbonated water if difficulty in swallowing. Stir until tablets disintegrate, drink liquid with pellets immediately or within 15 min, or administer through a gastric tube. Do not chew or crush pellets. Adults: The recommended dose is 20 mg esomeprazole (one tablet) per day. It might be necessary to take the tablets for 2-3 consecutive days to achieve improvement of symptoms. Duration of treatment is up to 2 weeks. Once complete relief of symptoms has occurred, treatment should be discontinued. If no symptom relief is obtained within 2 weeks of continuous treatment, the patient should be instructed to consult a doctor. Elderly (≥ 65 years old): As per adults. Paediatric population (< 18 years): Not recommended. No relevant use in this group in the indication: “short-term treatment of reflux symptoms (e.g., heartburn and acid regurgitation)”. Severe impaired renal function: Caution. Severe liver impairment: 20 mg max daily dose. Contraindications: Hypersensitivity to esomeprazole, substituted benzimidazoles or any of the excipients. Not with nelfinavir. Warnings and Precautions for Use: On demand treatment: Contact a physician if symptoms change in character. In the presence of any alarm symptom (e.g. significant unintentional weight loss, recurrent vomiting, dysphagia, haematemesis or melaena) and when gastric ulcer is suspected or present, malignancy should be excluded, as treatment with esomeprazole may alleviate symptoms and delay diagnosis. Treatment with proton pump inhibitors (PPIs) may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter and in hospitalised patients, also possibly Clostridium difficile. Patients should consult their doctor before taking this medicinal product if they are due to have an endoscopy or urea breath test. Absorption of vitamin B12 may be reduced due to hypo- or achlorhydria. Not recommended for long-term use as the following may also occur: Hypomagnesaemia; Risk of fracture. Consider stopping Emazole Control in cases of Subacute cutaneous lupus erythematosus (SCLE) accompanied by arthralgia. Interference with laboratory tests: Increased Chromogranin A (CgA) level may interfere with investigations for neuroendocrine tumours. To avoid this interference, Emazole Control treatment should be stopped for at least 5 days before CgA measurements. If CgA and gastrin levels have not returned to reference range after initial measurement, measurements should be repeated 14 days after cessation of PPI treatment. Contains glucose and sucrose. Interactions: Effect of esomeprazole on other drugs: Co-administration with atazanavir is not recommended. If the combination of atazanavir with a PPI is judged unavoidable, close clinical monitoring is recommended in combination with an increase in the dose of atazanavir to 400 mg with 100 mg of ritonavir; esomeprazole 20 mg should not be exceeded. Esomeprazole is a CYP2C19 inhibitor. When starting or ending treatment with esomeprazole, the potential for interactions with drugs metabolised through CYP2C19 should be considered. Serum levels of cilostazol, cisapride, tacrolimus, methotrexate may be increased. An interaction is observed between clopidogrel and esomeprazole, but the clinical relevance is uncertain. As a precaution, concomitant use of esomeprazole and clopidogrel should be discouraged. Gastric acid suppression by PPIs increase or decrease absorption of drugs with pH dependent absorption (decreased absorption of ketoconazole, itraconazole); esomeprazole inhibits CYP2C19 metabolising enzyme and could increase plasma concentrations of diazepam, citalopram, imipramine, clomipramine, phenytoin (monitor plasma levels of phenytoin), etc. resulting in need of a dose reduction; monitor INR when given with warfarin or similar. Caution as absorption of digoxin can increase. Effect of other drugs on esomeprazole: CYP2C19 and CYP3A4 inhibitors (clarithromycin, voriconazole) may increase the esomeprazole exposure. Dose adjustment not regularly required, except in severe hepatic impairment and long-term use. CYP2C19 and/or CYP3A4 inducers (rifampicin and St. John’s wort) may lead to decreased esomeprazole serum levels by increasing the esomeprazole metabolism. Pregnancy and Lactation: Caution in pregnancy due to lack of clinical data. No studies in lactating women, therefore, not recommended during breast-feeding. Ability to Drive and Use Machinery: Minor influence on the ability to drive or use machines. Adverse reactions such as dizziness (uncommon) and blurred vision (rare) have been reported. If affected, patients should not drive or use machines. Undesirable Effects: Common: Headache, abdominal pain, constipation, diarrhoea, flatulence, nausea/vomiting, fundic gland polyps (benign). Uncommon: Peripheral oedema, insomnia, dizziness, paraesthesia, somnolence, vertigo, dry mouth, increased liver enzymes, dermatitis, pruritis, rash, urticaria, fracture of the hip, wrist or spine. For other side effects refer to the SPC. Marketing Authorisation Holder: IQ Pharmatek Ltd., Gurtnafleur, Old Waterford Road, Clonmel, Co. Tipperary. Marketing Authorisation Number: PA 22777/001/001. Further information and SPC are available from: Rowex Ltd, Bantry, Co. Cork. Freephone: 1800 304 400 Fax: 027 50417. E-mail email@example.com Legal Category: Not subject to medical prescription. Date of Preparation: September 2019 Adverse events should be reported. Reporting forms and information can be found on the HPRA website (www.hpra.ie) or by emailing firstname.lastname@example.org or by emailing Rowex email@example.com
Urinary incontinence can result in significant suffering, including psychological problems and social isolation, sexual issues, lack of sleep due to nocturia, constipation from limiting fluid intake and falls and fractures in older people who have to rush to the toilet. Bladder control problems have a significant effect on the quality of life of sufferers on a physical, emotional and social level. Continence is a necessity for comfortable social adjustment and conversely, urinary incontinence frequently causes profound psychological and social consequences and restricts social activities. Urinary incontinence can occur when the normal process of storing and passing urine is disrupted. This can happen for a number of reasons, with certain factors increasing the likelihood of incontinence developing; advancing age is the biggest risk factor. Stress incontinence occurs when the pressure inside the bladder as it fills becomes greater than the strength of the urethra to stay closed. Additional pressure to the bladder such laughing or sneezing can then cause urine to leak. Weak or damaged pelvic floor muscles or an inadequate urethral sphincter can result in the urethra opening when it shouldn’t. These problems can be caused by: • Damage during childbirth, particularly a vaginal delivery. • Increased pressure on the abdomen, for example during pregnancy or if obese. • Surgical damage to the bladder or nearby area caused, for example, during a hysterectomy or removal of the prostate gland in men (prostatectomy). • Birth defects such as a defective bladder or sphincter. • Menopause, where the reduction in oestrogen results in the bladder becoming lax.
• Some medicines. Urge incontinence is the urgent and frequent need to pass urine, which can be caused by a problem with the detrusor muscles in the walls of the bladder. These muscles relax to allow the bladder to fill with urine and contract when going to the toilet to let urine out. If these muscles contract too often then this creates an urgent need to go to the toilet – this is known as an overactive bladder. Frequent contraction of the detrusor muscles can be caused by: • Drinking too much alcohol or caffeine. • Poor fluid intake, which causes strong, concentrated urine to collect, irritating the bladder. • Constipation. • Conditions such as urinary tract infections (UTIs) and bladder tumours. Overflow incontinence (also called chronic urinary retention) is often caused by a blockage or obstruction of the bladder. The bladder fills as normal but cannot empty completely because of an obstruction causing pressure to build up behind it, causing leaking around the blockage. An obstruction can be the result of an enlarged prostate gland in men, bladder stones and constipation. Total incontinence occurs when the bladder cannot store any urine at all. This results in large amounts of urine being passed constantly or passed occasionally with frequent leaking. It can be caused by birth defects, spinal cord injury and bladder fistulas. Assisting and Advising Urinary incontinence can result in significant suffering, including psychological problems and social isolation, sexual issues, lack of sleep due to nocturia, constipation from limiting fluid intake and falls and fractures in older people who have to rush to the toilet. Since urinary incontinence is a very common problem, pharmacists and their teams have many opportunities to support and help their customers. Even though incontinence has a significant impact on people’s lives, many sufferers write it off as getting older. It can be a difficult topic to raise and yet there is much that can be done to manage the condition. • Consider moving to the consultation room starting any conversation with “we have a more private area for consultations, would this be preferable?”
24 | PHARMACYNEWSIRELAND.COM
• If an individual raises their incontinence with you, then acknowledge that this is a difficult subject for them but avoid telling them how they should feel • Consider asking open questions to allow the patient to tell you more about what is happening to them, how they feel and what they are doing to manage the issue themselves o How often do you have an urgent urge to use the toilet? o What makes your symptoms worse? o What have you done so far to manage the symptoms? o How does this affect your everyday activities? o How often do you wake at night to use the toilet? o What symptoms concern you the most? o What impact does this have on everyday activities? • Avoid telling the individual what to do, instead ask them what they have considered and ask whether they would like you to advise on the options available to them.
• Handheld urinals • A catheter, a thin tube that is inserted into the bladder to drain urine • Devices that are placed into the vagina or urethra to prevent urine leakage – for example, during exercise Treatments The treatment a medical professional will recommend for urinary incontinence will depend on the type of incontinence a patient has and the severity of their symptoms. If the incontinence is caused by an underlying condition, they may receive treatment for this alongside incontinence treatment. Conservative treatments, which don't involve medication or surgery, can be recommended first. These include: Lifestyle changes • reducing caffeine intake caffeine is found in tea, coffee and cola, and can increase the amount of urine the body produces • altering how much fluid is drunk a day - drinking too much or too little can make incontinence worse
• losing weight
While incontinence products aren't a treatment for urinary incontinence, they are useful for managing the condition while a person is waiting to be assessed or for treatment to take effect.
Pelvic floor muscle training (Kegel exercises)
• Absorbent products, such as incontinence pants or pads. Liners, pads, disposable underwear, and reusable underwear absorb moisture. Products made for incontinence control catch the leaks and pull moisture away from the skin. That allows sufferers to go longer between changes. Many disposable pads, liners, and undergarments have a waterproof backing. This helps prevent overflow from reaching clothes. The waterproof systems use a "breathable" plastic film that helps reduce skin irritation.There's also a range of disposable undergarments with built-in protection - not just in the crotch, but throughout the entire garment. Styles range from pull-ons with elasticised legs and waists resembling a traditional cloth underwear to underwear that slips on with Velcro or adhesive tabs for a customised fit. There are also open-sided "thong style" pants held together by straps in the front and back that rest on top of the hip bone. Incontinence bed sheets are also available.
The pelvic floor muscles are the muscles used to control the flow of urine as the body urinates. They surround the bladder and urethra, the tube that carries urine from the bladder outside the body. Weak or damaged pelvic floor muscles can cause urinary incontinence, so exercising these muscles is often recommended. A GP may refer a patient to a specialist to start a programme of pelvic floor muscle training. The specialist will assess whether the person is able to squeeze (contract) their pelvic floor muscles and by how much. If they can contract their pelvic floor muscles, they'll be given an individual exercise programme based on their assessment. Bladder training When diagnosed with urge incontinence, one of the first treatments offered is bladder training. Bladder training may also be combined with pelvic floor muscle training if a person is suffering from mixed urinary incontinence. It involves learning techniques to increase the length of time between feeling the need to urinate and passing urine. The course will usually last for at least six weeks.
“Revive Active is how I take care of me so I can take care of everyone else. I simply wouldn’t be without it. Made in Ireland. Made for me.”- Sharon Tuthill from Cork
Revive Active is a super supplement with 26 active ingredients working in synergy providing adults with a daily dose of vitamins, minerals and amino acids in one convenient daily sachet. Made in Ireland, Revive Active was created for busy hectic lives and is the easy way to put back what life takes out.
Email: firstname.lastname@example.org • Web: reviveactive.com
Pharmacy role in addressing HIV-related Stigma HIV-related stigma remains a very current issue and community pharmacists, alongside their teams, can play a key role in supporting those with HIV in a range of ways. Community pharmacy can play a key role in encouraging uptake of HIV screening both through the sale of licensed HIV self-testing kits and/or provision of in-store HIV screening. The availability of HIV testing in the pharmacy setting is helpful in normalising and removing the associated stigma, which in turn can drive uptake and improve overall diagnosis rates. A key advantage of in-store testing is that the pharmacist is on hand to explain the result and its implications, provide professional advice and support, and signpost to relevant local services. The HSE Sexual Health and Crisis Pregnancy Programme (SHCPP) has recently launched a new campaign to address HIV-related stigma. HIV-related stigma can happen when misconceptions about HIV lead to negative attitudes towards people living with HIV or misunderstandings about what it means to receive a HIV diagnosis. HIV-related stigma can affect the mental wellbeing of people who
are living with HIV. Fear of being discriminated against or judged negatively can prevent people living with HIV from disclosing their HIV status or accessing treatment. HIV-related stigma can also deter people who may have been exposed to HIV from testing because they fear getting a positive result.
Campaign posters with the tagline: ‘Effective treatment means you can’t pass HIV onto partners’, will appear in public transport, social venues and college locations across the country, as well as on digital platforms. The campaign also references the global U=U campaign (undetectable equals untransmittable).
HIV infection is manageable. Effective treatment allows people living with HIV to remain healthy and can restore health in those who have become unwell with HIV infection. Furthermore, effective HIV treatment also prevents HIV being passed on to others. It is very important that these messages are communicated widely to ensure that people living with HIV know that they can live long and healthy lives and do not have to worry about passing on HIV to others. It is also very important that the public are aware of the progress that has been made in HIV treatment in relation to preventing sexual transmission and to encourage people who may have been exposed to HIV not to be concerned about having a HIV test.
The campaign was developed by the HSE SHCPP in consultation with community groups and sexual health NGO organisations. Funding for the campaign was provided by the Department of Health as part of the HIV Fast Track Cities Initiative. Dr Fiona Lyons, Consultant Physician at the GUIDE clinic, says, “It is important that people have access to early testing and treatment for HIV. Effective treatment prevents HIV-associated illness for those living with HIV and reduces the level of virus in the body to an undetectable level, so that HIV cannot be transmitted to sexual partners.” Maeve O’Brien, Interim Lead for Sexual Health and Crisis
Pregnancy, adds, “There is still a lack of understanding around HIV and what it means to live with HIV today and it’s important to address this. This public awareness campaign will improve people’s understanding of HIV and highlight the importance of early testing and treatment for HIV.” The HSE published its Position on Antiretroviral Therapy for all people living with HIV in July 2017, which recommends that “all people living with HIV attending HIV services in Ireland are offered antiretroviral therapy as soon as possible and informed of the benefits of antiretroviral therapy in improving their personal health and reducing HIV infectiousness.” The international UNAIDS targets for 2020 are that: • 90% of all people living with HIV know their HIV status • 90% of those diagnosed are receiving HIV treatment • 90% of those on HIV treatment are virally suppressed
Life Pharmacies raise almost ¤2,000 Two Life Pharmacies in Limerick have raised €1,825 to support local community services. In Kilmallock, Fogarty’s Life Pharmacycollected ¤1,100 for the Dromcollogher Respite Centre. The centre opened in 2002 and was the first of its kind in Ireland. It was created to provide “wholesome and professional care” to the ill and elderly of Limerick and North Cork. In Dooradoyle, O’Malley’s Life Pharmacy raised ¤725 following a coffee morning held in December. The proceeds were donated to the Raheen branch of the Society of St. Vincent de Paul. St. Vincent de Paul is the largest voluntary charitable organisation in Ireland. Both pharmacies would like to thank their staff, patients and customers for their donations in support of these two important community organisations.
Seamus Stack founder of Dromcollogher Respite Centre is presented with the donation from the staff at Fogarty's Life Pharmacy
Staff at O'Malley's Life Pharmacy present their cheque to the Raheen branch of the Society of St Vincent de Paul
PrEP Pre-exposure prophylaxis (PrEP)
Emtricitabine/Tenofovir disoproxil Mylan 200 mg/245 mg film-coated tablets
PRESCRIPTION ONLY MEDICINE. FURTHER INFORMATION IS AVAILABLE ON REQUEST OR IN THE SUMMARY OF PRODUCT CHARACTERISTICS. Mylan Ireland, Newenham Court, Northern Cross, Malahide Road, Dublin 17, Ireland. www.mylan.ie Job Code: EMT-2019-0027 Date of Preparation: November 2019
hen patients experience muscle and joint pain, pharmacists can recommend topical analgesics (rubs, creams and sprays) to help provide relief for their symptoms.
Helping customers choose the right topical analgesic for their individual needs is key if they are to gain optimum benefit. For patients, topical treatments that act at the site of pain make intuitive sense. For pharmacists, they are a valuable addition to their treatment choice. Topicals are used for those conditions that have an inflammatory component to their pain, such as osteoarthritis or acute musculoskeletal injuries. Patients largely use topical treatments as adjunctive therapy, unless they are unable to take oral medications. Where the pain is localised, topicals can be as effective as oral treatments but with fewer side-effects – which can be highly motivating for patients. Musculoskeletal pain is likely to affect a significant percentage of the population and encompasses
a huge range of conditions. Low back pain, for example, is acknowledged to be the leading cause of disability worldwide and osteoarthritis is purported to affect 60% of 60-year-olds.
warranted. External analgesic products may contain one or more of the following ingredients: methyl salicylate, camphor, menthol, methyl nicotinate, capsicum, and trolamine salicylate.
While musculoskeletal conditions and the pain, stiffness and immobility that go with them can compromise the lives of sufferers in many obvious physical ways, mental health and wellbeing is also affected.
Patients will often use OTC topical analgesics for the treatment and management of musculoskeletal injuries and disorders. These products may have local analgesic, anaesthetic, antipruritic, and/or counterirritant effects. Topical analgesics for musculoskeletal pain can be used alone or in conjunction with oral analgesics when appropriate and
28 | PHARMACYNEWSIRELAND.COM
Patient confusion regarding the wide array of topical products and formats available can also hinder usage. Consumers want help and reassurance when it comes to selftreating. They do not understand the difference between various types of topical – hot, cold and non-steroidal anti-inflammatory drugs – or how to use them. Following the introduction of the codeine regulations, pharmacists now encourage the use of acetaminophen as first in line choice of pain relief, followed by ibuprofen, before codeinebased analgesics.
In addition, patients must be made aware of how to use the medication properly and must be informed by pharmacists of the possible side effects that can occur when a product is used after the recommended period of three days. Products may have local analgesic, anaesthetic, antipruritic, and/or counterirritant effects. Topical pain killers, or analgesics, are sprayed on or rubbed into the skin over painful muscles or joints. Although all are designed to relieve pain, different products are made up different ingredients. NSAIDs, such as ibuprofen and diclofenac, act by inhibiting the cyclo-oxygenase enzyme to reduce prostaglandin production. These are usually available as gels, creams or sprays, but the amount of NSAID found in plasma is usually less than 5%. Cochrane
NEW LOOK. SAME POWERFUL PAIN RELIEF. For more information on sales and media plans, contact your Valeo Healthcare Sales Representative or Account Manager Biofreeze® and Performance Health are registered trademarks of Performance Health or its afﬁliates. ©2018 Performance Health. All rights reserved. *By chiropractors, physical therapists, massage therapists and pharmacist
data conclude that topical NSAIDs provide good pain relief, while avoiding the adverse effects of oral NSAIDs, when used for acute musculoskeletal problems. In terms of efficacy, one study found a topical ibuprofen gel was as effective as maximum dose oral ibuprofen in relieving sprains and strains when used for seven days. Counterirritants are approved for the topical treatment of minor aches and pains of muscles and joints. They are often employed for the treatment of acute musculoskeletal injuries and as an adjunct therapy in the treatment of chronic musculoskeletal disorders. Counterirritants differ from other external analgesics in that pain relief results more from nerve stimulation than depression. Topical analgesics for musculoskeletal pain can be used alone or in conjunction with oral analgesics when appropriate and warranted. External analgesic products may contain or more of the following ingredients: methyl salicylate, camphor, menthol, methyl nicotinate, capsicum, and trolamine salicylate. Superficial cold therapy (e.g. ice, cold gels, sprays, patches) is used to reduce inflammation, pain and oedema. Cold therapy forms a core element of the PRICE treatment approach to sprains and strains.
Superficial heat therapy (e.g. heat patches, hot water bottles) works by increasing the temperature of the skin and underlying tissue, increasing blood flow to promote healing of the affected muscle or joint and stopping pain signals from reaching the brain.
moderate pain for no longer than seven days. The factors that a pharmacist may consider when recommending a topical analgesic include dosage form, cost, ease of use of product, as well as the patient’s medical history, including possible allergies.
Salicylates: These same ingredients that give aspirin its pain-relieving quality are found in some creams. When absorbed into the skin, they may help with pain, particularly in joints close to the skin, such as the fingers, knees, and elbows.
Capsaicin: The main ingredient of hot chilli peppers, capsaicin is also one of the most effective ingredients for topical pain relief. When first applied, capsaicin creams cause a warm tingling or burning sensation. This gets better over time. Users may need to apply these creams for a few days up to a couple of weeks before they will notice relief from pain. Topical analgesic products are available in a variety of formulations, including gels, ointments, creams, lotions, and patches in single-entity or combination formulations. Topical heat therapy patches are also available in various sizes for treating joint and muscle pain and provide eight to 12 hours of continual, portable heat therapy. OTC topical analgesics are intended to be used for mild to-
30 | PHARMACYNEWSIRELAND.COM
All topical analgesic products should be kept well away from the eyes, mouth and mucous membranes, and should not be applied to broken skin. The hands should always be washed after use. Topical analgesics should not be used on young children, whose skin is more sensitive than adults’ and in whom reactions are therefore more likely. Salicylate-containing preparations should not be used by patients sensitive to aspirin. Topical NSAIDs are generally well tolerated; occasional local reactions have been reported, but these resolve on withdrawal of treatment. They should not be used with occlusive dressings. The systemic side-effects associated with oral NSAIDs can occur with topical agents, and the risk is increased with application of large amounts. Topical NSAIDs (except benzydamine) are contraindicated in patients who are sensitive to aspirin and other NSAIDs. They are not recommended for use by pregnant or breastfeeding women, or for children under 14 years of age. Serum levels of NSAIDs
after topical administration are low, and clinically significant drug interactions are unlikely. Pain Management Advice Community pharmacy teams are often the first healthcare personnel people turn to for advice about pain, so it pays to be up to date on current thinking about the best ways to manage musculoskeletal pain as it is so common. Guidance for musculoskeletal pain sufferers is to take exercise and stay active. Regular exercise can improve range of movement and joint mobility, increase muscle strength, reduce stiffness and boost energy, and will also help people maintain a healthy weight and ease pressure on their joints. Staying active is probably the most important piece of advice. This is the one thing that has been shown over and again to have the most benefit in the short- and long-term for any kind of pain. That is not to say that it will cause a reduction in pain, but maintaining activity ensures that muscles and joints do not stiffen up, become deconditioned or weak, which can make ‘getting going again’ when the pain reduces much harder. Also, maintaining movement helps to reassure the nervous system that nothing terrible is happening and can reduce overprotective behaviours, which can be debilitating in the longer term.
#AsthmaMatters General Election Manifesto The Asthma Society of Ireland has published its #AsthmaMatters manifesto, setting out the priority election issues for people with asthma and their families. Key among these is the need for urgent action on air pollution. About 7 million people a year die prematurely from air pollution globally and, in the first year of the outgoing government, almost 1,200 people died in Ireland due to air pollution. The Asthma Society’s #AsthmaMatters Manifesto 1.End all preventable asthma deaths in Ireland - Conduct a national review of asthma deaths and set out a comprehensive plan to end all preventable asthma deaths. 2. Substantially reduce the cost of asthma medication Recognise asthma as a long-term illness and provide cover under the Long Term Illness Scheme. 3. Immediately improve treatment of Severe Asthma patients - Establish a national funding model for high-tech severe asthma treatments.
Ensure all patients with severe asthma have regular access to a respiratory consultant.
and severe asthma patients under the Chronic Disease Management Programme
4. Guarantee access to emergency asthma medication for all school children Immediately review current ministerial regulations to allow schools and other organisations to purchase emergency asthma medication without prescription.
Substantially increase investment in diagnostics for children
5. Deliver best-in-class care for all forms of asthma, from diagnosis and assessment to end of life care - Publish and implement an end-to-end model of care for asthma. Prioritise every child with asthma
Intensify recruitment of specialist paediatric hospital doctors and nurses Adequately resource e-Health as a priority 6. Protect the right of Ireland's residents to Clean Air - Publish a comprehensive Clean Air Strategy. Conduct a public education campaign on the link between air pollution and health, targeted
at healthcare professionals and vulnerable populations. Prioritise investment in public transport, cycling and walking infrastructure over major road infrastructure. Invest in low emission solutions across transport, housing and energy sectors Phase out the sale and use of smoky solid fuels. Retain the Warmth and Wellbeing scheme for people with chronic respiratory conditions and expand it nationwide.
Lifelong Learning in Pharmacy Event The 13th International Life Long Learning in Pharmacy Conference is coming to Dublin, Ireland, from the 3rd to the 6th of July 2020. The Royal College of Surgeons in Ireland (RCSI) is delighted to host this extraordinary pharmacy education event at its historic St Stephens Green campus. Develop your knowledge and skills in the field of pharmacy education through a variety of educational programmes, hear from world renowned leaders presenting internationally significant research and development and network with colleagues from around the globe. With over 100 contributed papers, workshops and posters, and a remarkable list of keynote speakers including Zubin Austin (Canada), Mary E Collins (Ireland) and Rose Marie Parr (Scotland), this is a must-attend pharmacy event. Our online registration portal and abstract submission will open soon. Further details can be obtained by visiting www. https://lllpharm2020.com/
Agreeing Medicine Goals in Pharmacy The team at Pharmapod recently agreed 2020 strategic goals with their valued partners, International Pharmaceutical Federation (FIP) in The Hague last month. Pictured are members Paul Fahy and Leonora O’Brien with Dr Catherine Duggan, CEO, Carola Van der Hoeff - Kruijmer, COO, both FIP
These goals are aligned with the World Health Organisation’s global patient safety challenge to reduce severe, avoidable harm related to medicines by 50% in the next five years.
Meanwhile, Congratulations to Leonora O'Brien , CEO and Founder of Pharmapod – the Global Learning System, who was nominated for the second year in a row at the 2nd Irish Women’s Awards. This year, Leonora is a finalist among many fantastic women for ‘Business Women of the Year’. Leonora was privileged to have won the ‘Business of the Year’ award last year for her work with Pharmapod – we wish her every great success again this year!”
SYMBICORT ® (budesonide/formoterol)
SYMBICORT TURBOHALER IS NOW A PREFERRED RELIEVER* in moderate-to-severe asthma patients on top of Symbicort® maintenance1
SYMBICORT® Turbohaler® is indicated for children (6 years), adolescents (12-17 years) and adults (18 years) in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting ß2-adrenoceptor agonist) is appropriate: patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting ß2-adrenoceptor agonists; or patients already adequately controlled on both inhaled corticosteroids and long-acting ß2adrenoceptor agonists. SYMBICORT® Turbohaler® 100/6 Maintenance and Reliever is indicated for use in adults and adolescents (12 years and older). SYMBICORT® Turbohaler® 200/6 Maintenance and Reliever is indicated for use in adults and adolescents (12 years and older). SYMBICORT® Turbohaler® 400/12 is indicated in adults and adolescents aged 12 -17 years as a maintenance treatment only. In this document, the Maintenance and Reliever dosage regimen is also described as ‘SYMBICORT® Turbohaler® as-needed reliever with maintenance’. * GINA 2019 guidelines have positioned low dose ICS-formoterol as the preferred reliever to use in moderate to severe asthma patients (GINA steps 3 to 5) over a SABA in addition to their ICS/LABA maintenance therapy.
ABRIDGED PRESCRIBING INFORMATION SYMBICORT® TURBOHALER® 100 micrograms/6 micrograms/inhalation, inhalation powder. SYMBICORT® TURBOHALER® 200 micrograms/6 micrograms/inhalation, inhalation powder. SYMBICORT® TURBOHALER® 400 micrograms /12micrograms /inhalation, inhalation powder (budesonide/formoterol fumarate dihydrate) Consult Summary of Product Characteristics (SmPC) before prescribing. Indication: Indicated in adults, adolescents aged 12 years and older and children aged 6 years and older (100/6 only), for the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: 1) patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β2 adrenoceptor agonists or 2) patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists. Symbicort 100/6 is not appropriate for patients with severe asthma. Symbicort 200/6 and 400/12 only: Indicated in adults aged 18 years and older for the symptomatic treatment of patients with COPD with FEV1 <70% predicted normal (post-bronchodilator) and an exacerbation history despite regular bronchodilator therapy. Presentation: Inhalation powder. Symbicort 100/6: Each metered dose contains budesonide 100mcg/inhalation and formoterol fumarate dihydrate 6mcg/inhalation. Symbicort 200/6: Each metered dose contains budesonide 200mcg/inhalation and formoterol fumarate dihydrate 6mcg/inhalation. Symbicort 400/12: Each metered dose contains budesonide 400mcg/inhalation and formoterol fumarate dihydrate 12mcg/inhalation. Dosage and Administration: Asthma: The dose should be titrated to the lowest dose at which effective control of symptoms is maintained. Symbicort maintenance therapy: Patients should be advised to have their separate rapid-acting bronchodilator available for rescue use at all times. Adults (18 years and older): 100/6 and 200/6: The recommended dose is 1-2 inhalations twice daily. Some patients may require a maximum of 4 inhalations twice daily. 400/12: 1 inhalation twice daily. Adolescents (12-17 years): 100/6 and 200/6: The recommended dose is 1-2 inhalations twice daily. 400/12: 1 inhalation twice daily. Children 6-11 years (100/6 only): The recommended dose is 2 inhalations twice daily. Children under 6 years: Not recommended. Symbicort 400/12 is not recommended for children under 12 years. Symbicort maintenance and reliever therapy: 100/6 and 200/6 only (not indicated with 400/12 strength) Adults and adolescents (12 years and older): The recommended maintenance dose is 2 inhalations per day, given either as one inhalation in the morning and evening or as 2 inhalations in either the morning or evening. Patients should take 1 additional inhalation as needed in response to symptoms. If symptoms persist after a few minutes, an additional inhalation should be taken. No more than 6 inhalations should be taken on any single occasion. A total daily dose of more than 8 inhalations is not normally needed, a total daily dose of up to 12 inhalations could be used for a limited period. Patients using more than 8 inhalations daily should be strongly recommended to seek medical advice. Children under 12 years: Not recommended. COPD (200/6): The recommended dose in adults is 2 inhalations twice daily. COPD (400/12): The recommended dose in adults is 1 inhalation twice daily. Elderly: No special dosing requirements required. Patients with hepatic or renal impairment: Increased exposure is expected in patients with severe liver cirrhosis. Symbicort 200/6: Patients taking Symbicort as reliever, preventative use of Symbicort for allergen- or exerciseinduced bronchoconstriction should be discussed between physician and patient. The recommended use should take into consideration the frequency of need. In case of frequent need of bronchodilation without corresponding need for an increased dose of inhaled corticosteroids, an alternative reliever should be used. Contraindications: Hypersensitivity to active substance(s) or excipients. Warnings and Precautions: Recommended that the dose is tapered when the treatment is discontinued and should not be stopped abruptly. If treatment is ineffective, or exceeds the highest recommended dose, medical attention must be sought. Sudden and progressive deterioration in control of asthma or COPD is potentially life threatening and patient should undergo urgent medical assessment. Consideration should be given for increased therapy with corticosteroids, e.g. orally, or antibiotic treatment if infection present. Patients should have their rescue inhaler available at all times. Patients should be reminded to take their maintenance dose as prescribed, even when asymptomatic. Once asthma symptoms are controlled, consideration may be given to gradually reducing the dose. Patients should not be initiated on Symbicort during an exacerbation or if they have significantly worsening or acutely deteriorating asthma. Paradoxical bronchospasm may occur with an immediate increase in wheezing and shortness of breath after dosing. Symbicort should be discontinued immediately and an alternative therapy instituted if necessary. Systemic effects may occur, particularly at high doses prescribed for long periods e.g. Cushing’s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma, and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children). Recommended that height of children receiving prolonged treatment is regularly monitored and if growth is slowed, therapy should be re-evaluated and consideration given to referring the patient to a paediatric respiratory specialist. If adrenal function is impaired from previous systemic steroid therapy, care should be taken when transferring patients to Symbicort therapy. Patients transferring from oral steroids may remain at risk of impaired adrenal reserve for a considerable time. HPA axis function should be monitored regularly. Prolonged treatment with high doses of inhaled corticosteroids may result in clinically significant adrenal suppression. Additional systemic corticosteroid cover should be considered during periods of stress such as severe infections or elective surgery. Rapid reduction in dose of steroids can induce acute adrenal crisis, symptoms may include anorexia, abdominal pain, weight loss, tiredness, headache, nausea, vomiting, decreased level of consciousness, seizures, hypotension and hypoglycaemia. Treatment with systemic steroids should not be stopped abruptly. Transfer from oral steroid therapy to Symbicort may result in the appearance of allergic or arthritic symptoms such as rhinitis, eczema, muscle and joint pain. Specific treatment should be initiated for these conditions. In rare cases, tiredness, headache, nausea and vomiting can occur due to insufficient glucocorticosteroid effect and temporary increase in the dose of oral glucocorticosteroids may be necessary. To minimise risk of oropharyngeal candida infection, patients should rinse mouth with Date of Preparation: December 2019 Veeva Approval ID: IE-1571
water after inhaling doses. Concomitant treatment with itraconazole, ritonavir or other potent CYP3A4 inhibitors should be avoided. Observe caution in patients with thyrotoxicosis, phaeochromocytoma, diabetes mellitus, untreated hypokalaemia, hypertrophic obstructive cardiomyopathy, idiopathic subvalvular aortic stenosis, severe hypertension, aneurysm or other severe cardiovascular disorders such as ischaemic heart disease, tachyarrhythmias or severe heart failure. Observe caution when treating patients with prolongation of the QTc-interval. Re-evaluate need for Symbicort in patients with active or quiescent pulmonary tuberculosis, fungal and viral infections in the airways. Hypokalaemia may occur at high doses of β2 adrenoceptor agonists. Particular caution recommended in unstable or acute severe asthma. Monitor serum potassium levels. As for all β2 adrenoceptor agonists, consider additional blood glucose monitoring in diabetic patients. Visual disturbances may be reported with systemic and topical corticosteroid use. If a patient presents with these symptoms, consideration to ophthalmologist referral should be given to evaluate possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy. The excipient lactose contains small amounts of milk proteins, which may cause allergic reactions. 100/6: The reliever inhalations should be taken in response to asthma symptoms but are not intended for regular prophylactic use e.g. before exercise, separate rapid-acting bronchodilator should be considered. 200/6: Complete withdrawal of inhaled corticosteroids should not be considered unless it is temporarily required to confirm diagnosis of asthma. 200/6 & 400/12: An increase in the incidence of pneumonia, including pneumonia requiring hospitalisation, has been observed in patients with COPD receiving inhaled corticosteroids. Physicians should remain vigilant as clinical features of such infections overlap with symptoms of COPD exacerbations. Risk factors include current smoking, older age, low BMI and severe COPD. Potential effects on bone density should be considered especially in patients on high doses for prolonged periods that have co-existing risk factors for osteoporosis. Drug Interactions: Potent CYP3A4 inhibitors (e.g. ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin, telithromycin, nefazodone and HIV protease inhibitors) are likely to increase plasma levels of budesonide and concomitant use should be avoided. If this is not possible the time interval between administration should be as long as possible. Symbicort maintenance and reliever therapy is not recommended in patients using potent CYP3A4 inhibitors. Not to be given together with beta-adrenergic blockers (including eye drops) as can weaken or inhibit the effect of formoterol, unless compelling reasons. Concomitant treatment with quinidine, disopyramide, procainamide, phenothiazines, antihistamines (terfenadine) and TCAs can prolong the QTc-interval and increase the risk of ventricular arrhythmias. L-Dopa, L-thyroxine, oxytocin and alcohol can impair cardiac tolerance towards β2-sympathomimetics. Concomitant treatment with MAOIs, including agents with similar properties such as furazolidone and procarbazine, may precipitate hypertension reactions. Elevated risk of arrhythmias in patients receiving anaesthesia with halogenated hydrocarbons. Concomitant use of other beta-adrenergic drugs or anticholinergic drugs can have a potentially additive bronchodilating effect. Hypokalaemia may increase the disposition towards arrhythmias in patients taking digitalis glycosides. Hypokalaemia resulting from beta2-agonist therapy may be potentiated by concomitant treatment with xanthine derivatives, corticosteroids and diuretics. Pregnancy and Lactation: Use only when benefits outweigh potential risks during pregnancy and breastfeeding. Budesonide is excreted in breast milk; at therapeutic doses, no effects on child are anticipated. Not known whether formoterol passes into human breast milk. Undesirable Events: Consult SmPC for full list of side effects. Common: Headache, palpitations, tremor, candida infections in the oropharynx, coughing, mild irritation in the throat, hoarseness and pneumonia (in COPD patients using Symbicort 200/6) Uncommon: Tachycardia, muscle cramps, aggression, psychomotor hyperactivity, anxiety, sleep disorders, nausea, dizziness, blurred vision and bruises. Rare: Hypokalaemia, cardiac arrhythmias including atrial fibrillation, supraventricular tachycardia and extrasystoles, bronchospasm and immediate and delayed hypersensitivity reactions including exanthema, urticaria, pruritus, dermatitis, angioedema and anaphylactic reaction. Very rare: Depression and behavioural changes (predominantly in children), angina pectoris, prolongation of QTc-interval, hyperglycaemia, taste disturbances, Cushing’s Syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract, glaucoma and variations in blood pressure. Paradoxical bronchospasm may occur in very rare cases. Package Quantities: Each Symbicort Turbohaler 100/6 or 200/6 contains 120 inhalations. Each Symbicort Turbohaler 400/12 contains 60 inhalations. Legal Category: Product subject to prescription which may be renewed (B) Marketing Authorisation Numbers: PA 1019/020/001-003 Marketing Authorisation Holder: AstraZeneca AB SE-151 85 Södertälje, Sweden Further Information Available on Request From: AstraZeneca Pharmaceuticals (Ireland) DAC, Block B, Liffey Valley Office Campus, Dublin 22. Tel: +353 1 609 71 00. SYMBICORT and TURBOHALER are trademarks of the AstraZeneca group of companies. Date of API preparation: 09/2019 API REF: IE-1557 Adverse events should be reported directly to: HPRA Pharmacovigilance. Website: www.hpra.ie. Adverse events should also be reported to AstraZeneca Patient Safety on Tel: +353 1 6097100. References: 1: GINA Guidelines 2019.
Educational: Dysphagia Diet Dr Órla Gilheaney from the Department of Clinical Speech and Language Studies at TCD, explains the new International Dysphagia Diet Standardisation Initiative (IDDSI); a grading system being introduced in Ireland and around the world for safety reasons. Swallowing
Swallowing problems (also known as “dysphagia”) happen when you have difficulty moving foods and/or drinks from your mouth to your food-pipe. Around 5% of the general population will have trouble swallowing at some point during their life, with people who have certain medical conditions such as stroke, Parkinson’s disease, dementia and head and neck cancer reporting these problems more frequently. People with heart conditions such as congestive heart failure or ischaemic heart disease can also sometimes experience swallowing problems and may report a range of symptoms including, coughing or choking on foods and fluids, fatigue and breathlessness during meals, reduced food or fluid intake, weight loss or chest infections. These issues can not only impact on a person’s physical health but can also affect their quality of life, socialisation, and enjoyment of eating. Some people with swallowing problems need to take “softer” foods, which require less chewing or “thicker” drinks, which are easier and safer to swallow. These modified foods and fluids are typically recommended by a Speech and Language Therapist (SLT) after a clinical examination. In Ireland, patients with dysphagia were previously advised to take different “textures” of diets (e.g.: texture A soft diet or texture B minced and moist diet) based on their specific needs. If patients
to-date information on the safest consistency to continue taking.
Unmodified: Regular Foods
Level 7: Regular
What about fluids?
Level 7a: Regular Easy to Chew
The way that we describe the thickness of fluids will also change from “grades” to “levels” (see table below).
Texture A: Soft
Level 6: Soft and Bite-Sized
Texture B: Minced and Moist
Level 5: Minced and Moist
Texture C: Smooth Pureed
Level 4: Pureed
Texture D: Liquidized
Level 3: Liquidized
needed modified drinks, they were advised to take different “grades” of fluids, based on the thickness of the liquid (e.g.: grade 1-4 fluids). These labels were used across Ireland, but different names were used in other countries, leading to confusion among patients, caregivers, clinicians, and researchers.
This aims to improve global safety of and communication about modified foods and drinks, with the ultimate goal of improving dysphagia care. This framework will be rolled out across Ireland between September 2019 and April 2020.
What is IDDSI?
Foods will now be classified as different “levels”, rather than “textures” (see table above).
To reduce this confusion, the International Dysphagia Diet Standardization Initiative framework (IDDSI) has developed new common terms to describe food textures and drink thickness.
The key change from previous Irish labels include the use of separate “easy to chew” and “soft and bite–sized” levels. For tthose taking a modified diet, their SLT will be able to provide up-
Although these names have not changed too much, the way that individuals prepare their drinks may now be different. For example, the type of scoop that used and the number of scoops of powder that is needed to add to a drink may change, depending on the thickening product. The labelling on new tins of thickener will now use the IDDSI terminology. New tins will have visible information stickers on their lids. Finally, some people with dysphagia use pre-thickened drinks. With the IDDSI changeover, it is important that they consult your healthcare provider as the names and labelling of these drinks may change.
Unmodified Regular Fluids
Level 0 Thin
Grade 1 Very Mildly Thick
Level 1 SlightlyThick
Grade 2 Mildly Thick
Level 2 Mildly Thick
Grade 3 Moderately Thick
Level 3 Moderately Thick
Grade 4 Extremely Thick
Level 4 Extremely Thick
Topic Team Training – Dermatitis A community pharmacy environment that fosters teamwork ensured high levels of consumer satisfaction. This series of articles is designed for you to use as guide to assist your team in focusing on meeting ongoing CPD targets and to identify any training needs in order to keep the knowledge and skills of you and your team up to date.
Irritant contact dermatitis can occur in anyone who is exposed to irritants for a sufficient amount of time. Both types of contact dermatitis can cause skin to become red, blistered, dry and cracked. Sometimes, it is possible to have both irritant and allergic contact dermatitis at the same time. Irritant contact dermatitis is more common than allergic contact dermatitis. Irritants cause up to 8 out of 10 cases of contact dermatitis. Three-quarters of all contact dermatitis cases affect the hands. It is also more common in women, with approximately 1 in 5 women experiencing contact dermatitis on their hands at some point during their lives. This may be because women are exposed to more environmental factors that cause contact dermatitis. Contact dermatitis can develop at any age and can affect anybody. Treatment
The below information, considerations and checklist provides support to enable you to run a team training session and identify opportunities for learning within the topic of Dermatitis. Contact dermatitis is inflammation of the skin that occurs when sufferers come into contact with a particular substance. It can cause red, itchy and scaly skin, and sometimes burning and stinging. Contact dermatitis is a type of eczema. This is the name for a group of skin conditions that cause dry, irritated skin. There are several other types of eczema, including: • atopic eczema (also called atopic dermatitis), which often runs in families and is linked to other conditions, such as asthma and hay fever
• discoid eczema, which usually affects adults and causes circular or oval patches of eczema • varicose eczema, which occurs on the legs, usually around varicose veins (swollen and enlarged veins) Types of contact dermatitis
body's natural defence system, which reacts abnormally to the allergen. The first time this happens, the body becomes 'sensitised' to the allergen. The next time someone comes into contact with the allergen, the body 'remembers' the previous exposure and it causes a reaction.
Treatment for contact dermatitis involves using emollients to soothe the skin. An emollient is a moisturiser applied to the skin to reduce the loss of water from the skin. Corticosteroid medicines can be used to treat severe symptoms. With treatment, most people with contact dermatitis can expect their symptoms to improve at least partially. In up to two out of five people, the condition will clear up completely.
There are two types of contact dermatitis: • allergic contact dermatitis this is caused by an allergen (a substance that causes an immune response in the skin) • irritant contact dermatitis this is caused by an irritant (a substance that damages the skin physically) Allergic contact dermatitis involves the immune system, the
Consider: Is my advice on use of emollient therapy effective and up to date? Do we spend time with customers explaining how to effectively fit emollient therapy into their daily routine? Can I tailor my advice to individual customers, their lifestyles and preferences? Do I communicate the importance of liberal application of emollients, particularly after bathing or showering? Do we display emollients and related products in the pharmacy?
36 | PHARMACYNEWSIRELAND.COM
Check your pharmacy team are aware and understand the following key points:
Include POS with associated conditions relating to this category
How to give a clear explanation to customers about the role of urea in emollient products
Ensure efficient sign posting and shop floor management with associated ailments linked for maximum cross aisle merchandising
The importance of asking questions to enquire about symptoms Comon causes and signs of dermatitis and other associated skin conditions Ensure that the pharmacy team gives appropriate advice on the correct use and application of emollients Train pharmacy assistants to ensure that they can meet all the points in this training checklist
Ensure there is a discreet area in which staff can assist with advice and product selection Dedicated window displays will improve the shoppers experience and highlight the pharmacy Ensure the team are able to communicate lifestyle advice Train the team to meet all the above considerations
ACTIVELY NEUTRALISES BAD BREATH FOR 12 HOURS
free. If sensitivity Do not use if you ents. Keep out of 12 years of age.
Provides daily protection for sensitive teeth*
Starch Hydrolysate, ne, Aroma, Zinc hexidine diacetate,
HELPS REDUCE SENSITIVITY OF TEETH* PROVIDES DAILY PROTECTION FOR SENSITIVE TEETH* RELIEF FOR SENSITIVE TEETH*
FLUORIDE FOR DAILY STRENGTHENING OF TEETH SOFT MENTHOL FLAVOR ALCOHOL-FREE
Patent no. 1156777
www.cb12.ie *When used twice daily after brushing. Mylan IRE Healthcare Limited, Unit 35/36, Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland. www.mylan.ie Job code: CB12-2019-0160 Date of preparation: June 2019
ORAL CARE AGENT
ORAL CARE AGENT
Bad breath for 12 hours
ula of CB12 with ely neutralizes t masking it. gives prolonged . Recommended
is scientifically ective relief for er brushing. strengthen the
UCE SENSITIVITY OF TEETH* AILY PROTECTION FOR SENSITIVE TEETH* SENSITIVE TEETH*
FOR DAILY STRENGTHENING OF TEETH SOFT MENTHOL FLAVOR ALCOHOL-FREE
Actively Neutralizes Bad breath for 12 hours
The ‘Scope’ of Pharmacy OTC Scope has a strong Irish heritage, as the family name Freyne has been working within the healthcare sector here in Ireland for over 80 years and crossing three generations.
Tom Freyne, CEO, Scope Healthcare
“Our new product development and R&D department at Scope is constantly growing and we are always looking at ways to improve what we have currently and are also very excited about the pipeline of products we are going to bring to the Irish market” PHARMACYNEWSIRELAND.COM
Jack Freyne, a pharmacist (Freynes pharmacy, Clondalkin) established a number of companies in this area. His vision was to supply healthcare professionals and patients with high quality, effective and innovative products. This ethos remains today as the cornerstone of Scope. When Jack died in 1979 his legacy was continued by his son Garrett who successfully expanded the business into areas such as ophthalmology all the while maintaining the ethos set by his father.
Gets to Work Instantly Gets to Work Instantly
Gaviscon Extra chewable chewable tablets. tablets. Gaviscon Gaviscon Extra Extra oral oral suspension. suspension. For For the the relief relief of of Heartburn Heartburn & & Indigestion. Indigestion. For For Gaviscon Extra the the use use in in adults adults and and children children 12 12 years years and and over. over. ALWAYS ALWAYS READ READ THE THE LABEL. LABEL. Date Date of of Preparation: Preparation: November November 2018, 2018, IRL/G-OTC/1118/0033
Next Generation Today, Scope, which was formed in 2008, is led by Garret's son Tom, who tries to continue the ethos that his grandad and father set in this eyecare and healthcare company, by bringing some of the most innovative products to the Irish market. Irish Pharmacy News recently spoke with Tom to gain further insights into the current scope of their market and the challenges and opportunities for the future. Scope was formed in June 2008 and launched its first product in 2009. “Our vision was always to bring innovative products to the eye care market,” says Tom. “Our goal there was to collaborate closely with eyecare specialists and to ensure that our products were improving the quality of life of patients. We have since entered new areas other than eyecare but always keeping the same principles.” Tom is currently the CEO of Scope - and also founder of Scope, having started the business with his brother John over 10 years ago. He holds a degree in business and a Masters in Marketing and worked for Tattersalls, Bausch & Lomb, Numark and Nutricia all in marketing and sales roles. “As my father and grandfather both had healthcare business’ it was the natural next step for John and I to start something in that space,” he adds. Broad Range of Customers So what does a current CEO’s role involve within the day to day running of Scope? “I have a very active role in the day to day running of the company,” Tom says. “What’s nice is that we have a broad set of customers and
“We see independent pharmacies as well as chains in Ireland enrolling very innovative systems and services to offer a best in place primary care provider service for patients. I see community pharmacy in Ireland as a lot more advanced than some of the other countries that we work in” I get to spend time with them all for various projects and meetings across the year. “We have an incredibly strong and passionate team right now so it’s really exciting to see what we are working on and what we are involved in.” Tom lists new entrants to the market as amongst one of their biggest challenges during 2019.
of Scope. Tom adds, “This now sees us with over 100 staff in three different countries and 60 products in the market. We also grew the Irish business by 30% last year and added some very exciting new products to the mix for Irish patients and Healthcare Professionals.”
“We worked towards overcoming this by ensuring our products are innovative and unique and are keeping in touch with our patients.
Scope has a very sound footing within the community pharmacy market; They own a family pharmacy, Freynes pharmacy in Clondalkin, which was established in 1935 and is still family run and going strong.
“Our new product development and R&D department at Scope is growing and we are always looking at ways to improve what we have currently and are also very excited about the pipeline of products we are going to bring to the Irish market.
Looking at the pharmacy arena he adds, “Overall the Community Pharmacy plays a vital role in the Irish Healthcare, often alleviating the over-flowing GP practices and offering patients excellent standard of care in their communities.
“Also, we will be working closely with our HCP’s to ensure they are aware of the key differentiators of the Scope range and and have access to peer reviewed studies we have for our range of products,” he adds. Celebrating Milestones 2019 marked the 10th anniversary
“We see pharmacies in Ireland enrolling very innovative systems and services to offer a best in place primary care provider service for patients. I see community pharmacy in Ireland as a lot more advanced than some of the other countries that we work in.
Challenges in the Future What challenges and opportunities does Tom see on the horizon for pharmacists moving into 2020? “Moving into 2020 there are challenges for Community Pharmacy such as lack of government backing, VAT, increased regulation and bureaucracy in general. Pharmacists can build on the role they play as trusted advisor to the community and continue to take the pressure off the GP practice. In our area of focus we have seen pharmacy really grow and prioritise their OTC offerings and we feel together as partners this should most definitely be a large area of focus for pharmacies in Ireland. “With regards to the biggest obstacles, increased bureaucracy is making the industry not as attractive to work in and causing a shortage of new pharmacists,” he reflects. What is on the horizon for Scope in 2020? “Lots of exciting and innovative products and services in the pipeline and looking forward to our next 10 years in the business in Ireland.”
Pharmacy Students host Conference The Irish Pharmaceutical Students' Association recently attended a Mental Health Conference called “In Between Two Minds”, created by talented classmate Edel Burton and her team on the UCC Pharmacy Society. Edel Burton, Sanja Aleksić, Michael Vranken, EPSA - European Pharmaceutical Students'Association, Emer Lynch, Anthony Maher and Alanna Hynes, Irish Pharmaceutical Students Association pictured with conference attendee
The second part of the day consisted of the second full IPSA team meeting. They were joined by two delegates from the EPSA - European Pharmaceutical Students' Association, Sanja Aleksić and Michael Vranken, and the three Presidents of each Irish PharmSoc, Emer Lynch, Anthony Maher and Alanna Hynes. These relationships are important for the continuity of Pharmacy Student Representation on both a national and international level, says Lauren O’Reilly, IPSA Vice-President of Public Relations. Pictured are all those from the Students Association in attendance.
Genuair -has it ‘clicked’ yet? ®
The ONLY prefilled inhaler with visual and audible feedback for confirmed dose delivery 1-4
Genuair - a simple to use inhaler for patients with COPD 4
LAMA + LABA
LAMA Abbreviated Prescribing Information Eklira® Genuair® 322 micrograms inhalation powder. Please consult the Summary of Product Characteristics (SPC) for the full prescribing information. Presentation: Inhalation powder in a white inhaler with an integral dose indicator and a green dosage button. Each delivered dose contains 375 µg aclidinium bromide equivalent to 322 µg of aclidinium. Also, contains lactose. Use: Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Dosage: For inhalation use. Recommended dose is one inhalation of 322 micrograms aclidinium twice daily. Patients should be instructed on how to administer the product correctly as the Genuair inhaler may work differently from inhalers used previously. It is important to instruct the patients to read the Instructions for Use in the pack. No dose adjustments are required for elderly patients, or those with renal or hepatic impairment. No relevant use in children and adolescents. Contraindications: Hypersensitivity to aclidinium bromide or to any of the excipients. Warnings and Precautions: Stop use if paradoxical bronchospasm occurs and consider other treatments. Do not use for the relief of acute episodes of bronchospasm. Use with caution in patients with myocardial infarction in the previous 6 months, unstable angina, newly diagnosed arrhythmia within the previous 3 months, or hospitalisation within the previous 12 months for heart failure functional classes III and IV. Dry mouth, observed with anticholinergic treatment, may be associated with dental caries in the long term. Use with caution in patients with symptomatic prostatic hyperplasia or bladder-neck obstruction or with narrow-angle glaucoma. Do not use in patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption. Interactions: Do not administer with other anticholinergic-containing medicinal products. No other interactions expected. Please consult the SPC for more details. Fertility, pregnancy and lactation: No data on use in pregnancy. Risk to newborns/infants cannot be excluded. Consider risk-benefit before using during lactation. Unlikely to affect fertility at the recommended dose. Side-effects: Common (1-10%): Sinusitis, nasopharyngitis, headache, cough, diarrhoea, nausea. Uncommon (0.1- 1%): Dizziness, blurred vision, tachycardia, palpitations, dysphonia, dry mouth, stomatitis, rash, pruritus, urinary retention. Rare (0.01-0.1%): hypersensitivity. Not known: angioedema, anaphylactic reaction. Pack sizes: Carton containing 1 inhaler with 60 unit doses. Legal category: POM Marketing Authorisation Number: EU/1/12/778/002 Marketing Authorisation holder: AstraZeneca AB, SE151 85 Södertälje, Sweden. Marketed by: A. Menarini Pharmaceuticals Ireland Ltd., Castlecourt, Monkstown Farm, Monkstown, Glenageary, Co. Dublin A96 T924. Further information is available on request to A. Menarini Pharmaceuticals Ireland Ltd. or may be found in the SPC. Last updated: May 2018
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions to: HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2, Tel: +353 1 6764971, Fax: +353 1 6762517, Website: www.hpra.ie, e-mail: medsafety@ hpra.ie. Adverse events should also be reported to A. Menarini Pharmaceuticals Ireland Ltd. Phone no: 01 284 6744. Date of item: October 2019. IR-BRI-17-2019
1. MIMS Ireland October 2019 2. Eklira Genuair Summary of Product Characteristics, last updated February 2018 3. Brimica Summary of Product Characteristics, last updated August 2019 4. Magnussen, H et al. COPD. 2019 Apr;16(2):196-205
Abbreviated Prescribing Information Brimica® Genuair® 340 micrograms/12 micrograms inhalation powder. Please consult the Summary of Product Characteristics (SPC) for the full prescribing information. Presentation: Inhalation powder in a white inhaler with an integral dose indicator and an orange dosage button. Each delivered dose contains 396 µg aclidinium bromide (equivalent to 340 µg of aclidinium) and 11.8 micrograms of formoterol fumarate dihydrate. Also, contains lactose. Use: Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD). Dosage: For inhalation use. Recommended dose is one inhalation of 340 µg/12 µg twice daily. Patients should be instructed on how to administer the product correctly as the Genuair inhaler may work differently from inhalers used previously. It is important to instruct the patients to read the Instructions for Use in the pack. No dose adjustments are required for elderly patients, or those with renal or hepatic impairment. No relevant use in children and adolescents. Contraindications: Hypersensitivity to the active substances or to any of the excipients. Warnings and Precautions: Do not use in asthma. Stop use if paradoxical bronchospasm occurs and consider other treatments. Do not use for the relief of acute episodes of bronchospasm. Use with caution in patients with myocardial infarction in the previous 6 months, unstable angina, newly diagnosed arrhythmia within the previous 3 months, or hospitalisation within the previous 12 months for heart failure functional classes III and IV. Discontinue if increases in pulse rate, blood pressure or changes in ECG occur. Use with caution in patients with a history of or known prolongation of the QTc interval or treated with products affecting the QTc interval. Use with caution in patients with severe cardiovascular disorders, convulsive disorders, thyrotoxicosis and phaeochromocytoma. Hypokalaemia may occur, is usually transient and supplementation not needed. In patients with severe COPD, hypokalaemia may be potentiated by hypoxia and concomitant treatment. Use with caution in patients with symptomatic prostatic hyperplasia, urinary retention or with narrow-angle glaucoma. Dry mouth, observed with anticholinergic treatment, may be associated with dental caries in the long term. Do not use in patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption. Interactions: Do not administer with other anticholinergic and/or long-acting β2-adrenergic agonist containing medicinal products. Caution in use with methylxanthine derivatives, steroids, non-potassium-sparing diuretics, β-adrenergic blockers or medicinal products known to prolong the QTc interval. Please consult the SPC for more details. Fertility, pregnancy and lactation: No data on use in pregnancy. Consider risk-benefit before using during lactation. Unlikely to affect fertility at the recommended dose. Sideeffects: Common (1-10%): Nasopharyngitis, urinary tract infection, sinusitis tooth abscess, insomnia, anxiety, headache, dizziness, tremor, cough, diarrhoea, nausea, dry mouth, myalgia, muscle spasms, peripheral oedema, increased blood creatine phosphokinase. Uncommon (0.1- 1%): Hypokalaemia, hyperglycaemia, agitation, dysgeusia, blurred vision, tachycardia, electrocardiogram QTc prolonged, palpitations, angina pectoris, dysphonia, throat irritation, stomatitis, rash, pruritus, urinary retention, increased blood pressure. Rare (0.01-0.1%): Hypersensitivity, bronchospasm, including paradoxical. Not known: anaphylactic reaction, angioedema. Pack sizes: Carton containing 1 inhaler with 60 unit doses. Legal category: POM Marketing Authorisation Number: EU/1/14/963/001 Marketing Authorisation holder: AstraZeneca AB, SE-151 85 Södertälje, Sweden. Marketed by: A. Menarini Pharmaceuticals Ireland Ltd., Castlecourt, Monkstown Farm, Monkstown, Glenageary, Co. Dublin A96 T924. Further information is available on request to A. Menarini Pharmaceuticals Ireland Ltd. or may be found in the SPC. Last updated: October 2019 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@ hpra.ie. Adverse events should also be reported to A. Menarini Pharmaceuticals Ireland Ltd. Phone no: 01 284 6744.
McCabes Pharmacy findings on Skincare Over half of the Irish public fail to adjust their skincare routine for cold weather, according to new findings. Do you change your skincare routine to accommodate for cold weather?
Do you change your skincare routine to accommodate for cold weather?
However, protect skin from harsh weather conditions by using skincare products designed to keep it smooth and hydrated. 19.8%
6.2% 0.2% Yes
I didn't know it'd I don't have a make a difference skincare routine
In a survey conducted by McCabes Pharmacy, 54.1% of respondents said they don’t alter their skincare ritual during winter, and a further 6.2% said they didn’t know it would make a difference. While one in five respondents said they change their skincare regimen
during the winter months, a similar proportion confessed to not having a skincare regime at all. Further findings revealed that a third of the Irish public suffers from skin problems during winter including cracked lips, skin irritation and painful, dry skin.
Lisa Byrne, superintendent pharmacist at McCabes Pharmacy, says,“When your skin is dehydrated, it might seem logical to lather it with lots of hot, soapy water but this can actually worsen the dryness. It is recommended to avoid long hot baths, keep showers short and only use warm water.” If dryness isn’t acknowledged, skin can crack and cause bacteria to seep through. This can provoke cellulitis—a bacterial skin infection that can cause pain, redness and swelling. Selene Daly, dermatology clinical nurse specialist, at Sligo University
Hospital, adds,“Using a soap-free wash along with a moisturiser is a way of combating winter dry skin. Increasing the frequency of the moisturising along with changing to a greasier cream can also help.” Cream cleansers are gentler and helps hydrate the skin, while oil-based moisturisers form a protective layer and preserve extra moisture. Serums, night masks and night oil can also help to retain moisture. However, in order to prevent further dryness and irritation it’s advisable to avoid alcohol-based products, harsh peels and masks, as well as over-exfoliating and using harsh soaps. People who suffer from atopic eczema usually have extremely dry skin because it is incapable of retaining enough moisture. Cold and dry weather can commonly trigger the symptoms of this condition, which include dryness, cracking and itchiness.
United Drug – Shaping Future Healthcare Together
Growing year on year, United Drug are now celebrating their 14th year of success with the Pharmacy Show. For 2020 they have moved to a new venue to facilitate the show’s development and growth going forward.
attendees and exhibitors will now benefit from the venue’s ease of access, free parking, Wifi and lots more. To support the CPD element of the show, the event features a wide range of United Drug Guest Speakers and Workshops aimed at business growth and improved patient outcomes. In addition to this, attendees will have the opportunity to book a tour to visit the United Drug Facility in CityWest.
Hosted in the Citywest Convention Centre, Dublin,
Connecting all of Ireland’s pharmacy community with a large
Ireland’s Largest Retail Pharmacy Show 2020 takes place on April 19th and 20th - bringing together suppliers and customers from across the country and beyond.
number of manufacturers that are relevant to this population, it is the ideal platform from which to launch a brand - as previous suppliers have done to tremendous applause.
This is the premier networking event to connect with industry colleagues.
Furthermore, the Pharmacy Show offers the unique opportunity for suppliers to meet with their customers and to better understand what challenges the customers have to face, offering these suppliers an opportunity to discuss solutions they can bring to the marketplace.
Lucia Onofri, Brand and Trade Marketing Manager
For further information please contact:
Jennifer Morrin, Marketing Associate. Email: Pharmacy.Show@united-drug.com
Pharmacy Appointment for Cathy Cathy Harrison has been permanently appointed as Northern Ireland’s Chief Pharmaceutical Officer. She had been serving as the acting CPO since Dr Mark Timoney stepped down in December 2018, took up her permanent role at the start of last month. She is responsible for leading policy relating to Medicines Optimisation, Innovation, Pharmacist Prescribing, Pharmacy in the Community and Pharmaceutical Public Health. A qualified pharmacist, Cathy is the registrant of both the Pharmaceutical Society of Northern Ireland and the Royal Pharmaceutical Society of Great Britain. Speaking at an National Pharmacy Association (NPA) reception in Belfast recently, she said the pharmacists’ “skills are increasingly in demand.”
Ginger and curcumin (the active part of turmeric) are well known for their benefits f o r j o i n t heal t h : gi n ger hel p s t o mai n t a i n j o i n t mobi l i t y and avoi d mor n i n g st i f n ess, Nourish your Body! while curcumin helps to control inflammatory responses in the body. Vitamin C also plays an essential role, helping contribute to normal collagen formation and Fuel your Brain with Omega-3! the function of bones and cartilage. Available from:
Two great products to nourish your body from within and keep you feeling good throughout 2020.
The body needs omega-3s to develop and function optimally in every stage of life, so whether you’re doing exams or just looking to support brain function, Eskimo Brain 3.6.9 is the supplement for you.
The brain contains more than 100 billion cells working together to process information, form memories and recall. Each cell has an outer membrane which is actually made up of fat. Believe it or not, the typical human brain is actually about 60% fat, so we obviously need to include fats in our diets if we want to keep ‘mission control’ up and running. When it comes to fat, there is one fat that we do not need to cut back on - Omega-3s especially EPA* and DHA**.
The ginger and curcumin in the ZinCuFlex complex are in highly bio-available forms to aid absorption. This means greater levels of active curcumin can be released to support joint, brain and overal immune health. ZinCuFlex – which is gluten-free and suitable for coeliacs – also acts as a great all-rounder for general health. It helps promote general immunity, energy and vitality so you’l feel like the best version of yourself, from the inside out.
The European Food Safety Authority (EFSA) state that you need 250mg EPA and DHA daily to support heart function and 250mg DHA daily to support brain function and vision. Oily fish (sardines, anchovies, mackerel, salmon) are a direct source of both omega-3 EPA and DHA, so regular consumption of oily fish in the diet can help you stay physically and mentally active as you get older, thanks to the protective benefits these essential fatty acids have when it comes to your heart, brain and vision***.
Omega-3 DHA is vital for healthy brain function and plays very important roles in the structural integrity of brain cells, membrane fluidity, cell signaling and neurotransmission. Omega-3 EPA and DHA are considered essential as our body can’t produce them so they must be obtained through diet (oily fish, seeds, nuts) or supplementation. Without these important fats, it can become difficult to concentrate, learn new information, and balance moods properly. Surprisingly, a massive 89% of Irish people are not consuming sufficient oily fish in their diet, so unless you’re eating 2-3 portions of oily fish a week, an omega-3 supplement such as Eskimo Brain 3.6.9 is a must. With high levels of omega-3 DHA along with seed oils, vitamin D, E and CoQ10, your brain power will surge in no time.
Taking a daily fish oil supplement, naturally rich in omega-3 is a simple way to safeguard your health. Available in both lemon flavoured liquid or odourless capsules. Eskimo-3 is committed to delivering safe, sustainably sourced, effective omega-3.
* EPA - Eicosapentaenoic acid ** DHA - Docosahexaenoic acid *** The benefecial effect is obtained with intakes of 250mg EPA/DHA per day.
“I started taking ZinCuFlex after Nourish your Joints! badly injuring my kneecap in a fal . ZinCuFlex Ginger & Curcumin Complex (from €22.65) is available in all good Within days, swelling had reduced pharmacies and health food stores nationwide. and I had better joint mobility.” Joan Ahern, Kerry
ZinCuFlex Ginger & Curcumin Complex is an innovative all-in-one food supplement that helps to protect joints and maintain joint mobility. It contains a unique combination of high potency extracts of ginger and curcumin with vitamin C - all of which contribute towards the normal function of bones and cartilage. Ginger and curcumin (the active part of turmeric) are well known for their benefits for joint health: ginger helps to maintain joint mobility and avoid morning stiffness, while curcumin helps to control inflammatory responses in the body. Vitamin C also plays an essential role, helping contribute to normal collagen formation and the function of bones and cartilage.
The ginger and curcumin in the ZinCuFlex complex are in highly bio-available forms to aid absorption. This means greater levels of active curcumin can be released to support joint, brain and overall immune health. ZinCuFlex – which is gluten-free and suitable for coeliacs – also acts as a great all-rounder for general health. It helps promote general immunity, energy and vitality so you’ll feel like the best version of yourself, from the inside out.
Food supplements are available in all good pharmacies and health food stores. More Information - eskimo3.ie and zincuflex.ie
“I started taking ZinCuFlex after badly injuring my kneecap in a fall. Within days, swelling had reduced and I had better joint mobility.” Joan Ahern, Kerry
ZinCuFlex Ginger & Curcumin Complex (from €22.65) is available in all good pharmacies and health food stores nationwide.
Food supplements are available in all good pharmacies and health food stores. More Information - eskimo3.ie and zincuflex.ie
Perrigo Pharmacy Educational Event Perrigo Ireland recently hosted an educational training event at Dublin University. vision globally. We were delighted to be in a position to support an educational event organised by the Pharmacy Students Union from both Trinity and RCSI Dublin held in the Macneill Theatre on the Dublin University Campus. “The speakers on the night came from various backgrounds but all had one thing in common – a keen interest in promoting the idea of self-care! “One theme that landed on the night was definitely the idea that if you don’t look after yourself how can you expect to look after others. Darragh Connolly, IPU President, pictured right with Paul Hatton, National Field Sales Controller, Dr Adam Martin, The Fit Pharmacist and Laura Dowling, The Fabulous Pharmacist with speakers and guests from the Educational Self-care Event
Paul Hatton, National Field Sales Controller with Perrigo Ireland said, “ “Perrigo is committed to promoting and supporting self-care within
the OTC marketplace and the pharmacy community,” Paul Hatton, National Field Sales Controller with Perrigo Ireland said. “Self-care is central to our core
“The interest in self-care is high and mental health is clearly a huge part of this subject matter. The speakers on the night were not afraid to share examples where they faced adversity and overcame. “Truly an inspirational night and one we were delighted to be associated with.”
Women in Leadership Event The Pharmaceutical Managers’ Institute will hold their first Women in Leadership event for 2020, on February 27th in the Clayton Hotel, Liffey Valley Dublin. This lunch hosts Aldagh McDonogh, Group Chief Executive with global executive recruitment group Morgan McKinley. Founded 30 years ago by Irishman Pat Fitzgerald, Morgan McKinley now employs over 800 people and operates in France,the UK, Hong Kong, China, Australia, Canada, Singapore and Japan; as well as its offices in Dublin and Cork. Aldagh holds the position of Group CEO since March 2018 when the founder stepped back to the role of Chairman. Prior to this, Aldagh was the Transformation Director with the company. MC for this Women in Leadership lunch will be Deirdre Kelly, Country Manager with Consilient Health.
Allcare increase in Brand Awareness Allcare Pharmacy will continue as the main sponsor of The Ray D’Arcy Show on RTÉ Radio 1 into 2020. The move follows recent results from the December 2019 Pharmacy Brand Equity and Market Study by Coyne Research, which showed Allcare’s brand awareness with the highest year-on-year percentage point increase in the five-year history of the nationally-representative study of 1,000 adults. “We’re delighted to renew our partnership with The Ray D’Arcy Show,” said Siobhán Flynn, Marketing Director at Allcare Pharmacy. “We’re a strong community-based brand and look forward to continuing to promote the great things
customers and patients experience in Allcare Pharmacies.” The Ray D’Arcy Show, which airs weekdays from 3 p.m. – 4.30 p.m., is increasing in popularity, recent JNLR figures show. Allcare’s sponsorship includes 30 10-second stings aired every week during the show, each focused on specific benefits and services offered by the pharmacy group. In addition to these, Allcare will have credited promos every week on RTE’s other highest-rated shows, including Morning Ireland, Today with Sean O’ Rourke, Liveline, The Ryan Tubridy Show,
Saturday with Cormac Ó hEadhra and Sunday with Miriam as well as podcast sponsorship and homepage sponsorship. Allcare Pharmacy is now the largest Irish-owned pharmacy group. In addition to the investment it made in The Ray D’Arcy Show sponsorship, the increased brand awareness also reflects its increased store footprint following its acquisition of the Bradley’s group of pharmacies last year. It is planning continued growth through new franchises and acquisitions.
New study on Smoking Costs Smoking and exposure to second-hand smoke (SHS) cost the Irish health service an estimated ¤172 million in 2016 and resulted in more than 300,000 bed days, almost 21,500 day cases and 33,615 inpatient hospital admissions, a new study has revealed. The study, which is published in the latest issue of the Irish Medical Journal, used smoking data from the Healthy Ireland Survey, international figures as well as hospitalisation and cost data from the national Hospital inpatient Enquiry (HIPE) database for 2011-2016. It found that “in 2016, there were 21,486 day case admissions, 33,615 inpatient hospital admissions consuming 309,117 bed days, attributable to smoking and exposure to second-hand smoke, with an estimated cost of ¤172 million in publicly funded hospitals.” Furthermore, the study, which was carried out by researchers from the HSE Tobacco Free Ireland Programme, found that these figures represented 2% of day case admissions, 5% of inpatient admissions, and 8% of inpatient bed days for that year. This led the authors to conclude that, “smoking continues to cause a considerable impact on hospital services in Ireland.” According to the research, “figures from the World Health Organization (WHO) report that 7 million people die each year as a result of tobacco; more than 6 million of these deaths are as a direct result of smoking, with approximately 900,000 deaths among non-smokers as a result of exposure to second-hand smoke (SHS). In Ireland, in 2016, it is estimated that almost 5,950 people died as a direct result of smoking with an additional 100 deaths estimated to be as a result of exposure to SHS.” Further analysis revealed that respiratory conditions were the most common reason for smoking-related inpatient hospitalisation in 2016 followed by cardiovascular conditions and cancers.
Ostomy & Urology Care
We provide a complimentary cutting service for patient comfort, cutting between 5,000 and 8,000 bags per week. This service gives patients the highest level of security and comfort. We have invested in our state-of-the-art cutting machine for increased precision.
Contact us today for further information or to place an order:
01 463 2347 or online at www.udw.ie
The OTC and Retail Pharmacy
Product Awards 2020
The Irish consumerâ€™s drive towards the self-care, health and beauty market shows no signs of abating, making the over-the-counter arena the jewel in the crown of Irelandâ€™s community pharmacy retail sector. One of the most eagerly anticipated events in the Irish retail calendar, Irish Pharmacy News OTC and Retail Pharmacy Product Awards are the only industry awards that specifically recognises and rewards the companies and their products within the OTC market. The OTC and Retail Pharmacy Product Awards act as a celebration and showcase of product innovation, marketing and value to its customer. Originally launched in 2008, they are designed to recognise product development and innovation in the pharmacy sector. Over the following pages, we showcase those products which have been shortlisted as finalists across 20 categories, including Best Beauty Product, Best Product Marketing Campaign, Best Baby Product, and Best Product Innovation. As pressure on hospitals and doctors in Ireland grows, so does the emphasis on the pharmacist as the first link in the healthcare
chain. Pharmacy services, diagnostic testing and of course over-the-counter medicines and remedies now have a larger role to play that ever before. The pharmacy retail market has never been stronger. The OTC market is continuously face with threats from large supermarkets and budget retail chains. Product knowledge, education and marketing are factors that the retail pharmacist must develop a firm strategy for. The OTC Awards mark the standards of excellence and investment into product marketing that pharmacists use to add value to their customers. With outside retailers and the buying power of symbol groups ever on the increase, innovation across the OTC market is crucial. With the rise of the internet as both reference and shopping tool, consumers are now managing more and more ailments without the help of either doctor or pharmacist. However, the pharmacist does still have a key
role to play in helping their customers make informed healthcare decisions. With a greater emphasis being placed on self-care and self-medication, so is the emphasis placed on consumers and patients to ensure they select product that are safe and effective for their needs. All products entered will now be judged by an expert judging panel, which has been drawn from independent and multiple pharmacies across Ireland, during our official judging evening in the Red Cow Moran Hotel, Dublin. The 2020 Awards will take place on March 12th in the Radisson Blu Hotel, Stilorgan with over 150 Independent Pharmacists, Buyers, Distributors and suppliers expected in attendance.
Gosh Chameleon Foundation 2020 & Retail Pharmacy Product Awards
Best Beauty Product Despite the prolonged doom and gloom on the high street, waning consumer confidence, restricted budgets and the shadow of Brexit challenges, the beauty sector has far from lost its appeal. Indeed consumers will be prepared to pay even more over the next five years, with annual spend per head forecast to rise. Innovation continues to be a significant factor in the continued growth of the beauty OTC market in Ireland. With the category remaining highly competitive, innovation is just one way to maintain consumer interest in brands. This category was open to retail products available within community pharmacy within the key category of Beauty. These products may include, for example, cosmetics, body sprays & lotions and supplements for hair, skin and nails. The judging panel will consider OTC retail products which can demonstrate market reach, success and effectiveness within the Beauty market.
48 | PHARMACYNEWSIRELAND.COM
Following the success of Chameleon Primer, Gosh now present the Chameleon Foundation. It has a skin-loving formula which hydrates and protects the skin all day - enriched with smart pigment which transforms into a foundation shade to match skin tone giving a flawless, even and natural semi-matt finish with a fresh dewy glow. This presents a magical fusion of skincare and foundation. Chameleon Foundation is the ultimate all-in-one perfecting cream giving the skin a refreshed feeling while adding a hint of radiance. Say hello to a base that’s so natural, so luminous, it leaves admirers thinking the wearer woke up like that. Gosh are proud of the following Chameleon Foundation attributes • Vegan, • Perfume Free, • Allergy Certified, • 40% Packaging from Ocean Waste Plastic (OWP)
Perfectil Hair Crush Gummies Perfectil Hair Crush Gummies are an easy and delicious way to ensure hair is being given a little extra love and some great nutritional support. Everyone knows that beauty starts from within so the nutritional experts that created Perfectil, the UK’s No.1 beauty supplement brand have developed a natural mixed berry flavoured gummy supplement to nourish thehair from the inside out. This fabulous little chewable gummy is ideal for those who don’t like swallowing tablets. RSP: 23.99
Jenny Glow The Jenny Glow brand started off as a range of eight fragrances. There are now 45 different scents available, with the company having diversified into Scarves, Sunglasses, Body Care and Watches. Over the past two years Jenny Glow has been known as one of the strongest brands in Irish Pharmacies. Pomegranate is the number one seller for the third year in a row. The success of the brand is down to positive word of mouth, by very loyal customers. The company thankfully have a very high percentage of repeat customers due to the quality of the product. Longevity is one of the key reasons for success.
Solgar® Collagen Hyaluronic Acid Complex Solgar® understands that good nutrition is the foundation of beautiful skin. That’s why they created their Collagen Hyaluronic Acid Complex to nourish the skin from within. This unique complex includes a patented ingredient BioCell Collagen ll®, a unique and highly absorbable complex of hydrolysed collagen type II, hyaluronic acid, and chondroitin. With hyaluronic acid, clinically shown to reduce fine lines and wrinkles, increase skin hydration, and increase collagen content in the dermis to support skin structure and elasticity. Includes Vitamin C to promote the body’s own collagen formation and provide important antioxidant protection from damaging free radicals associated with premature aging. Discover beauty’s best kept secret.
PHARMACYNEWSIRELAND.COM | 49
Alflorex® 2020 & Retail Pharmacy Product Awards
Alflorex® is a ground-breaking product for Irritable Bowel Syndrome (IBS), a condition that affects up to 1 in 7 people in Ireland every day. Alflorex® should be taken daily to manage and prevent recurrence of all of the main IBS symptoms including: - abdominal pain - bloating, cramps & gas
Best Digestive Product According to Euromonitor, Irish consumers’ diets will continue to contain a high proportion of sugars and refined carbohydrates, despite growing concerns over obesity levels. Consumers are not getting enough fibre in their diets also, due to demand for convenience cooking and fast foods. Overall growth within the Digestive Remedies market is anticipated to be slower compared to the review period due to significant competition and falling unit prices in response to pressure from generic products. If costs increase for importing products into Ireland after Brexit and prices do go up in certain areas, consumers may seek to trade down to generics. This category was open to all OTC products available in Ireland for the treatment of digestive orders for enhancing gut health. These products may include those for heartburn, upset stomach, diarrhoea, constipation and bloating. The judging panel will consider products which can demonstrate targeted and effective relief, as well as an appreciation of the impact these digestive disorders have on the sufferer.
50 | PHARMACYNEWSIRELAND.COM
- unpredictable bowel movements like alternating diarrhoea and constipation The bacterial culture in Alflorex, 35624®, was discovered and developed in Ireland by small Irish company, PrecisionBiotics. It is one of the bestselling IBS products in pharmacies in Ireland (IQVIA Value Share Nov 2019), consistently praised and purchased by Irish consumers. It is also the No:1 recommended probiotic by US Gastroenterologists and Doctors*. *Among gastroenterologists and physicians who recommended a brand of probiotic in an AlphaImpactRx 2017 survey.
Digest Gold™ Enzyme deficiencies may result from a combination of age, diet and lifestyle. These deficiencies can lead to a variety of digestive discomforts, including occasional gas, bloating, indigestion and irregularity. Digest Gold™ is an advanced formula that breaks down carbohydrates, fats, fibre and protein. The enzymes in Digest Gold™ support optimal digestion by helping the body absorb nutrients and convert food into energy. Digestive well-being can improve concentration and increase vitality. Digest Gold™ is an excellent choice for individuals seeking a high-potency enzyme formula. RSP: 44.99
One Nutrition Gluten Shield
Bio-Kult Advanced Multi-strain
Gluten Shield provides relief from discomfort caused by residual gluten remaining in a Gluten Free Diet.
Bio-Kult is a scientifically developed multispecies, multi-strain supplement with 14 strains of beneficial bacteria. This means that Bio-Kult can deliver high concentrations of beneficial bacteria to the colonisation sites in the gut and therefore be able to help a more diverse range of digestive disorders.
Gluten Shield contains PROLYL OLIGOPEPTIDASE (AN-PEP)also known as PROLYL ENDOPEPTIDASE,which is an Aspergillus Niger derived enzyme. It is the only EU approved enzyme with novel food status and is proven to cut or break down the amino acid chains in gluten (see references 123). Suggested use: 1-2 tablets per meal to a maximum of 6 tablets per day or as recommended by a health practitioner. Best taken at the start of a meal. 1. The University of Kentucky, ‘The gluten-free choice: is it for me?’ 2. D. Stepniak et al., Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease’, Am J PhysiolGastrointest Liver Physiol’, 2006, vol 291 no 4:G621-9. 3. C. Mitea et al., ‘Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease’, Gut, 2008, vol 57 no 1, p25-32.
Bio-Kult has been proven to survive the high acidity of the stomach. It does not need to be refrigerated, is gluten free and suitable for children & pregnant women (always consult doctor first). It has also been clinically proven to reduce IBS gut symptoms* - 69% decrease in abdominal pain, 86% decrease in moderate to severe symptoms & 33.7% said their symptoms completely disappeared after 16 weeks.
PHARMACYNEWSIRELAND.COM | 51
Naturigin 2020 & Retail Pharmacy Product Awards
Best Hair, Nail and Scalp Health Product
Naturigin was founded by husband and wife Mette and Stig From Denmark. Mette was diagnosed with breast cancer. TThis forced them to rethink their lifestyle. Luckily, Mette recovered but this experience spurred them on to make a change and to avoid chemicals where possible. In the search for quality natural organic sustainable hair colour the family started their journey to create a healthier alternative to chemical hair colour. Naturigin was borne, available in 19 shades. Manufactured in Denmark using windfarm energy. Derived from 98.2% natural ingredients containing 12 organic Ingredients.
Consumers are becoming more confident in asking for advice about hair and scalp problems. There has been much media coverage about imminent â€˜curesâ€™ for baldness but this media speculation proves that the hair and scalp category is an important area for shoppers. The category has witnessed new product development over the last 12 months and this is expected to continue. Furthermore, nail care also plays an essential role within health, hygiene and beauty. With a growing sense of selfcare and awareness around fungal infections, a large proportion of the population are being driven towards maintenance of fingernails and toenails. This category was open to all OTC products within the sectors of hair, nail and scalp conditions, such as those for hair loss/thinning, medicated shampoos and treatments and those targeted dandruff, as well as those for nail fungal infections and nail beauty. Retail products are also considered.
52 | PHARMACYNEWSIRELAND.COM
Naturigin is suitable for Vegans, post chemo customers, customers with sensitive and itchy scalps, and people who care about the environment and sustainability. It is cruelty free.
Hair loss; it may not be life threatening but it can be life altering. It can be caused by hormonal changes, medical conditions, medications or childbirth. From the top botanical haircare brand Phyto created by Patrick Ales over 50 years ago comes the Phytonovathrix regime, the natural solution to all types of hair loss. Its formula uses 99% naturally derived or plant-based ingredients and offers a comprehensive action compared to competing products on the market.
Stress, hormones, illness, medication, poor nutrition, over-styling – there are so many factors that can cause hair growth disruptions.
Phytonovathrix Fortifying Shampoo gives hair strength and vitality thanks to Guarana extract, while Red algae extract coats the hair fibre for visibly thicker hair. With active ingredients such as Celery Seed Extract, which stimulates production of Wnt protein, and Baikal Skullcap Extract, which prolongs cellular life, Phytonovathrix Global Anti-Hair Loss Treatment, to be used in conjunction with the Fortifying Shampoo, works to slow down hair loss and stimulate hair growth resulting in denser and stronger hair.
Nailner Treat and Colour for Fungal Nails
Nourkrin® Woman, with unique ingredient Marilex® is scientifically formulated to help maintain a normal hair growth cycle and help to promote healthy hair growth. Nourkrin®’s market leader status is the result of more than 56 scientific studies and clinical papers, as well as several consumer studies published in leading peer-reviewed journals over the last 30 years. Today, Nourkrin® is recommended by doctors, dermatologists and trichologists the world over, plus it’s the only hair growth supplement to be awarded an unprecedented 2 gold medals by the hair experts at the World Trichology Society. In studies, more than 8/10 women reported an improvement in the growth, quality and appearance of their hair after taking Nourkrin®.
Nailner Treat & Colour combines treatment with breathable nail polish for healthy and beautiful nails all year round. Nailner Treat & Colour combines the technology of treating the infection while also covering the unsightly look on the nails allowing female sufferers to wear sandals or go barefoot with confidence. Nailner Treat & Colour is an extension of the Nailner brand, however it uses the innovative formula of covering the problem as well as treating the underlying issue. Nailner is proven effective against fungal nail infections (supported by clinical studies). Fungal Nail Infections are unsightly and therefore lead to embarrassment for many sufferers particularly in the summer months when sandals are the footwear of choice. Normal nail polish can hurt or worsen the issue. Nailner Treat & Colour treats the nail fungus as the nail polish covers the problem areas without worsening the nail fungus.
PHARMACYNEWSIRELAND.COM | 53
CALPOL® Vapour Plug Elave Paediatric & Nightlight sensitive Sun SPF 50+ 2020 & Retail Pharmacy Product Awards
Best Baby Product
The CALPOL® Vapour Plug & Nightlight provides up to 8 hours soothing night-time comfort. It releases soothing lavender and chamomile vapours that comforts the child through the night and helps with clear and easy breathing. Its soft, blue nightlight provides a gently reassuring glow, as well as guiding parents in the room so they can avoid disturbing their child while they rest. CALPOL® Vapour Plug & Nightlight is an electrical device and non-medicine.
Product innovation, attractive packaging, impact to the customer, unique selling point, and manufacturer support are all important if a baby product is to be successful in an already saturated marketplace. Some aspects of the babycare market have slipped away from pharmacies, as supermarkets entice parents with cut-price promotions and big brand offerings. However, infant and child health is still an important category, with newparents relying on their local Pharmacy for care and support.
54 | PHARMACYNEWSIRELAND.COM
Elave sensitive Sun Paediatric SPF 50+ offers very high broad spectrum UVA/UVB infrared (IR) thermal protection. Paediatrician approved from newborn, helps shield delicate skin from harmful UVA/UVB rays that cause sunburn. This water resistant sunscreen protects without irritating the skin. A lightwight non greasy formula which doesn't clog pores. Hypoallergenic and free from worrying chemicals. Peta Cruelty free and Vegan. Made in Ireland.
Milton Baby Care
BabyVitD3 is one of Irelands leading Vitamin D supplements for babies. BabyVitD3 Drops are pure Vitamin D drops in the Cholecalciferol form. With just 2 drops, the baby will received 5micrograms of Vitamin D3.
The Milton range and brand is a unique brand with over 70 years of history , specialising in hygiene and sterilisation products that protect our little ones from germs from birth.
It is now recommended that all babies in Ireland aged from 0 to 12 months whether breastfed or formula fed should receive 200 IU (5ug) of Vitamin D daily. BabyVitD3 has no preservatives, no parabens no artificial colours, no flavourings, no peanut additives, no sugars or lactose and no gluten. RSP: ¤11.99
The wide range of Milton products supports a 3-step routine. Step 1 - cleaning all baby utensils and accessories. Step 2 - sterilisation. Step 3 - washing and disinfecting the hands to limit any germ transmission.
Mustela Vitamin Barrier Cream 1 2 3 With a unique combination of patented active natural ingredients, extensive clinical studies have proven that Mustela Vitamin Barrier Cream 1 2 3 is the only nappy change cream that acts on all the essential elements of the skin barrier and has, overall, a higher protection action on the protection of the skin than any competitor on the market. The Mustela Vitamin Barrier Cream 1 2 3 not only prevents but also soothes and repairs irritations and redness from nappy rash. It provides complete action against all causes of nappy rash such teething, urine and diarrhoea. Mustela is the international skincare expert brand for babies, children, expectant and new mothers for over 60 Years. With 0% perfume and 0% preservatives such as phthalates and phenoxyethanol, Mustela Vitamin Barrier Cream 1 2 3 has been tested in extreme conditions and is guaranteed safe for daily use on babies from birth onwards.
PHARMACYNEWSIRELAND.COM | 55
Bio-Oil Dry Skin Gel 2020 & Retail Pharmacy Product Awards
Best Skincare Product
Bio-Oil Dry Skin Gel is the next generation in the treatment of dry skin. Improving on the existing dry skin technology of creams, lotions and body butters by replacing the in-active water (usually around 70%) in these formulations with oil, resulting in a product that is able to treat dry skin. Dry Skin Gel replenishes the skin’s barrier and deeply moisturises. The unique gelto-oil texture absorbs easily and creates a protective film to resist moisture loss and restore dry skin to its optimal hydrated state. In a clinical trial conducted on dry skin sufferers, 82% recorded an improvement in just two days.
Overall skin care in Ireland has seen steady retail value growth as its performance is not overly influenced by economic conditions. However, if consumer confidence does slow down there could be trading down to more affordable skin care products if consumers start to feel the pinch. The quest for youth is expected to continue among both male and female consumers. The global skincare market is fast growing and expansive, vast and evolving quickly with forecasts that indicate a global market of ¤81.9 billion in 2028, growing significantly from ¤44.1 billion in 2018.
56 | PHARMACYNEWSIRELAND.COM
PoxClin® Shingles Body Mousse From the makers of PoxClin® Chickenpox Cool Mousse. Pharmed are delighted to present PoxClin® Shingles Body Mousse, formulated to relieve the symptoms of shingles. A unique product designed to provide instant relief from skin irritation, helping to prevent scarring and infection whilst cooling, soothing and conditioning the skin; helping to accelerate the natural healing process. PoxClin® Shingles contains a patented bio-active bacterial blocker known as 2QR Complex. 2QR is a negatively charged polysaccharide extracted from the Aloe Barbadensis plant which effectively helps to protect the skin from bacterial infections. Shingles (also known as Varicella-Zoster) is a skin disease caused by a reactivation of the Chickenpox Virus. It is most common in older people but can occur in people of all ages. For further information contact: email@example.com
RELIFE Relizema cream
Elave Rejuvenating Cleansing Treatment
MooGoo's Irritable Skin Balm
Relizema, which helps manage conditions like eczema, dermatitis and dry and sensitive skin, is the first RELIFE product range to be rolled out in pharmacies nationwide. Ireland is the first country in the world outside of Italy to launch RELIFE as a dermatology (over-thecounter [OTC) brand.
Elave sensitive rejuvenating cleansing treatment with 12% Glycolic Acid Arginine complex exfoliates dead skin cells and actively rejuvenates skin, reducing signs of ageing and the appearance of fine lines.
MooGoo's Irritable Skin Balm is their flagship product. This unique balm is 100% natural, so natural in fact, it is edible.
The Relizema product range, which consists of six products, is aimed at managing eczema, dermatitis and dry and skin conditions in adults and children using a three-pronged approach – ‘Treat, Protect and Cleanse’. RELIFE’s Relizema cream helps to treat the symptoms of itching and redness, which are associated with dermatitis. Due to its dermaprotective action, it helps maintain and restore the physiological skin barrier and its formulation protects and moisturises the skin with a soothing effect.
Elave rejuvenating cleansing treatment actively promotes cellular regeneration and stimulates collagen synthesis to reveal younger, brighter skin. Suitable for all skin types. Peta cruelty free and vegan approved. Made in Ireland.
This anti-inflammatory, anti-fungal and wound healing treatment balm reduces redness, inflammation and stops itching. It is suitable for Eczema, Psoriasis and Sebhorrheic Dermatitis among other dry skin conditions. It can be used all over the body, including on the eyelids and inside the nose and ears. It can even be used on broken skin. Like all MooGoo products, the Irritable Skin Balm is suitable from birth. Contains Aloe Vera, Sage Oil and Centella Asiatica among other effective ingredients.
PHARMACYNEWSIRELAND.COM | 57
Brupro Max 400mg 2020 & Retail Pharmacy Product Awards
Best Pain Relief Product The pain relief market within Ireland is consistently rising. Pain relief products will continue to be in strong demand, with consumers leading busier and more stressful lifestyles, and seeking analgesics for pain relief, particularly from tension and headaches. More active consumers are also likely to require more pain relief for injuries. OTC analgesics used to treat pain can sometimes be particularly difficult for patients to self-manage. Community pharmacists and their teams have an opportunity to educate and advise within this area.
58 | PHARMACYNEWSIRELAND.COM
Brupro Max 400mg Film-coated tablets work where they’re needed - at the site of pain. They quickly relieve pain, reduce inflammation and lower temperature. Brupro Max provides fast and effective relief from: • headaches
• muscular pain
• dental pain
• cold and flu symptoms
• period pain
• fever • backache
Brupro Max 400mg Film-coated tablets: each tablet contains 400 mg of ibuprofen. The shelf life is 5 years. Available in packs of 12s and 24s. Always read the leaflet.
Nurofen Rapid Relief Liquid Tablets It has been a strong year of growth for the Nurofen brand in pharmacy. The big news of 2019 was the launch Nurofen Rapid Relief Liquid Capsules in February, which was supported by an extensive education program and backed by a highly effective above the line campaign. 125 million pain occasions were treated by Irish Pharmacy over 12 months and 40 million of these were treated with Nurofen. * Nurofen Rapid Relief Liquid Capsules were launched in February 2019 providing over the counter fast and effective pain relief to patients. ** Nurofen now accounts for 44% of the Mild Pain market. *** *IMS Data Aug 2019 **Nurofen Rapid Relief Maximum Strength 400mg Liquid Capsules contain Ibuprofen. For pain relief. Always Read the Label. ***IMS Data June 2019 ZINC No. IRL/CC/1219/0039. Date of preparation: Dec 2019
Voltarol Emulgel Extra Strength 2% w/w Gel
Argicalm is a new reusable hot/cold pack with natural clay to relieve aches and pains.
Unlike products that work by only cooling or heating the skin, Voltarol Emulgel Extra Strength 2% w/w Gel contains a non-steroidal anti-inflammatory drug (NSAID), called diclofenac. Voltarol 2% Gel is applied locally, targeting pain at the source. It works by blocking production of some of the body’s chemicals that cause inflammation, pain, tenderness and swelling.
Comfortable and convenient: The anatomic shapes and malleable clay conforms easily to the body to give a comfort fit with uniform coverage – no empty spots. The cotton washable sleeve is easily fixed in place with the velcro strap allowing ease of movement while the pack is on. Available in 5 different sizes to cover all patient needs: back, stomach, shoulder, neck, elbow, wrist, knee etc. For hot therapy: Heat in the microwave or hot water for relief from back pain, muscle and joint spasms/stiffness, cramps, stiff neck and abdominal pains. For cold therapy: Place in the freezer (min 2hrs) to reduce pain, reduce inflammation, bruising and swelling. Indicated for sprains, pulled muscles, arthritis, tendonitis, eye pain, toothache and bruising.
This product introduced innovation to the market in 2016 and continues to improve joint pain sufferers’ lives. With a ¤600k marketing investment in 2018, Voltarol drove the Topical Pain Category in Pharmacy and encouraged consumers to have conversations with pharmacists about managing their joint pain.
PHARMACYNEWSIRELAND.COM | 59
Revive Active 2020 & Retail Pharmacy Product Awards
Best Irish Pharmacy Brand Product In an increasingly borderless world, many consumers are favouring Irish pharmacy brand products. Research has shown that a brand’s country of origin can be as important as other purchasing criteria such as price and quality with many Irish pharmacy shoppers wanting to support local businesses, finding local more trustworthy and more attuned to their needs and wants.
Revive Active is an award-winning super supplement with 26 active ingredients working together, helping put back what life takes out. This super supplement is delivered in individual daily sachets which are added to water or juice offering higher bioavailability as vitamins and minerals dissolved in liquid form are absorbed in the body more easily than in tablet or capsule form. The unique blend of vitamins and minerals provide a multitude of health benefits which include naturally sustained energy, without the use of sugar and caffeine, as well as contributing to a normal immune system and heart health. With the unique combination of CoEnzymeQ10 and L-Arginine along with the 24 other active ingredients each sachet delivers multiple benefits. This product is suitable for vegetarians, vegans, diabetics and it is gluten free. Revive Active is the best source for increased naturally sustained energy, improved immune system function and heart health.
With OTC Products available from global companies also, Irish brands must work hard to establish themselves in order to get ahead of the competition.
60 | PHARMACYNEWSIRELAND.COM
Solvotrin ACTIVE IRON - Our mission is to make iron better Active Iron’s ground-breaking protein formula was developed to target the body’s natural ‘iron absorber’ in the small intestine, and is clinically proven to double the amount of iron absorbed compared to the gold standard iron sulphate. This means that more iron is available for your body to absorb. Active Iron’s Kind and Strong formula reduces gut irritation from iron, preventing the unwanted side effects usually associated with iron supplements such as constipation, stomach pain and nausea. Active Iron is kind enough to take on an empty stomach, while being strong on absorption.
Panadol includes variants Panadol Extra, Panadol Base, Panadol Actifast and Panadol Night.
Since 1934 the Gardiner family have been making traditional family skincare products over three generations since Joseph Gardiner created the first Family Skincare Apothecary in Ireland.
Solpadeine is Ireland’s Number 1* pharmacy only pain relief brand, with a value of ¤18.9m*. The brand has an extensive history in pharmacy. Solpadeine is for the treatment of acute moderate pain which is not considered to be relieved by other analgesics such as paracetamol or ibuprofen alone**.
For the first time, Panadol’s Irish heritage was brought to life through an innovative new brand campaign focusing on the fact that Panadol is Made in Ireland called ‘This is what we’re made of’. The campaign, which launched in September 2017, celebrates the brand’s Irish manufacturing ties and what it believes has been its “best-kept secrets”: namely that its manufacturing site, GSK in Dungarvan produces over 6 billion Panadol tablets every year, exporting to over 70 countries worldwide. The campaign features employees from the Waterford site, and aims to highlight its strong ties to Ireland and celebrate the Irish team who are such a big part of the brand’s global success story. Panadol continued focusing on its Made in Ireland campaign in 2018.
Their expertise in making traditional Ovelle apothecary products like Silcock's Base, Aqueous Cream and Emulsifying Ointment allowed the team to draw on advances in skincare to create innovative products such as Sulfate free Menthol Aqueous and Baby Aqueous. Manufactured in Ireland under the highest ethical Sedex and Environmental standards ISO 14001, All Ovelle formulations are safety tested to the highest international pharma standards and are independently certified.
Solpadeine provides pain relief from symptoms of headache, including migraine, toothache, backache, common cold, influenza, menstrual pain, musculoskeletal pain. The range includes a variety of formats to meet differing consumer needs. Perrigo acquired the Solpadeine brand in 2012 from GSK. Thanks to bespoke pharmacy training and extensive trade advertising by Perrigo, Solpadeine has 85% brand awareness*** in Ireland. The Solpadeine core value is to offer the right pain relief, to the right person, at the right time. *IMS MAT Value Sales Nov 2019 **Solpadeine SPC ***Pharma Focus research Wave Field 28th May to 12th June 2019 N=1,602 Pharma, N=1,000+ per core category
PHARMACYNEWSIRELAND.COM | 61
2020 & Retail Pharmacy Product Awards
Alflorex速 is a ground-breaking product for Irritable Bowel Syndrome (IBS), a condition that affects up to 1 in 7 people in Ireland every day.
Multi-Mam Compresses provide direct relief for breastfeeding discomforts such as sore or cracked nipples, infections and sensitivity. The compresses, which are placed on the affected nipple, are impregnated with a bio-active gel containing the natural 2QR-complex (Polysaccharides derived from the leaves of the Aloe plant).
Alflorex速 should be taken daily to manage and prevent recurrence of all of the main IBS symptoms including: - abdominal pain - bloating, cramps & gas
Best Natural Product More and more consumers are in search of natural solutions to their ailments, including both homeopathic remedies and supplements supportive of a healthier lifestyle.
- unpredictable bowel movements like alternating diarrhoea and constipation The bacterial culture in Alflorex, 35624速, was discovered and developed in Ireland by small Irish company, PrecisionBiotics. It is one of the bestselling IBS products in pharmacies in Ireland (IQVIA Value Share Nov 2019), consistently praised and purchased by Irish consumers. It is also the No:1 recommended probiotic by US Gastroenterologists and Doctors*. *Among gastroenterologists and physicians who recommended a brand of probiotic in an AlphaImpactRx 2017 survey.
Driven by consumer interest in all things natural, the market for natural products available over-the-counter has increased over the last number of years. Consumers are purchasing these for both prevention and immune boosting properties as well as to help aid healing when they are sick.
62 | PHARMACYNEWSIRELAND.COM
This gel neutralises harmful micro-organisms naturally thereby supporting the natural healing process and reducing the chance of infection. The gel is non-toxic and no preservatives have been added therefore its not necessary to remove the gel prior to breastfeeding. Multi-Mam Compresses are the number one recommendation by Midwives and Lactation Consultants.
Just Balm Just Balm is a fragrance-free, natural healing moisturising balm, which has been designed to nourish dry, irritated and itchy skin. This includes allergy and eczema prone skin. Just Balm also helps to moisturise sun and wind burn, shaving rash, nappy rash, scar treatment, flaky scalp, split ends, lip balm and general baby care. Suitable for use from head to toe for adults and children including babies.
One Nutrition B12-Max
ZinCuFlex® ZinCuFlex® is a new health food supplement with proven benefits for joint health. Combining the power of Ginger, Curcumin and Vitamin C, ZinCuflex® has been shown to support joint health. Ginger is an extract which helps to maintain joint mobility and avoid morning stiffness. Curcumin helps to control inflammatory responses in the body, helps to protect joints and helps to maintain joint flexibility.
One Nutrition B12-Max is a highly absorbable Vitamin B12 spray designed to support the immune system, energy levels and red blood cell formation*. One Nutrition is an Irish brand, based in Rathnew, Co.Wicklow, that has recently relaunched its packaging, making it almost 100% recyclable, and using free from ingredients to cater to a wide range of dietary needs.
ZinCuFlex® uses a patented complex, to improve absorption by up to 100 times compared to ordinary curcumin, making it more bioavailable and therefore more effective.
The convenient spray format has a natural orange flavour and is ideal for those with difficulty swallowing capsules, or for individuals with digestive or absorption issues. It’s particularly useful for those following a vegan or vegetarian diet, as vitamin B12 is only found naturally in animal sources such as fish, meat, eggs and dairy products. Vitamin B12 is required to prevent anaemia. It works with folic acid to regulate red blood cells and helps utilize iron.
ZinCuflex® is ideal for anyone looking to ease joint discomfort, sports injuries or support bones or cartilage.
*Vitamin B12 contributes to normal red blood cell formation, to the reduction of tiredness and fatigue to normal energy yielding metabolism and to the normal function of the immune system.
PHARMACYNEWSIRELAND.COM | 63
CB12 2020 & Retail Pharmacy Product Awards
Best Oral Health Product Oral care is set to continue to see positive retail value growth in the future months. Growth will be marginally slower compared to previous years due largely to a decline in demand for mouth fresheners and a falling need for dentures.
Bad breath is a condition that everyone can experience. Many people use mouthwash to eliminate bad breath, but mouthwash products are not all alike, some only mask the odour. CB12 mouthwash is different. Thanks to its unique, patented formula of Zinc and Chlorhexidine, it is clinically proven to actively neutralise bad breath for 12 hours1. Discover new CB12 Sensitive mouthwash. Providing daily protection against sensitive teeth.* CB12 Range includes Mouthwash, Toothpaste, Boost Gum and Spray. * When used twice daily after brushing 1 Seemann et al. Duration of effect of the mouthwash CB12 for the treatment of intra-oral halitosis: a double-blind, randomised, controlled trial, J Breath Res. 2016 Jun 22;10(3):036002, doi:10.1088/17527155/10/036002
Oral hygiene (and gum protection) is set to be an important trend among consumers as many younger consumers are aware of the effectiveness of introducing good oral hygiene to their oral care routine.
64 | PHARMACYNEWSIRELAND.COM
TePeÂŽ Interdental Brush The TePeÂŽ Interdental Brush is designed to clean the gaps between the teeth where a regular toothbrush is unable to reach. Daily use removes up to 40% more plaque than tooth-brushing alone, and helps prevent gum inflammation, cavities and bad breath. The TePe Interdental Brush is available in 9 colour coded sizes to fit narrow as well as wide gaps. Developed in collaboration with dental experts to certify the highest efficiency, comfort and quality, the TePe Interdental Brush is continuously tested and evaluated to meet the demands of consumers and professionals worldwide and ensure the highest quality in every detail.
Colgate Total new breakthrough technology, combines zinc and arginine to fight bacteria on the whole mouth. Teeth, tongue, cheeks and gums are protected for up 12 hours.
With its slim rounded Diamond Shaped Head, the VirtueBrush Floss Tip Bamboo Toothbrush is designed to maximise brushing reach and comfort.
Marvis ,“the haute cuisine of toothpastes” is a refreshing, creamy toothpaste in a mint flavour that whitens and protects teeth while freshening the breath.
The Floss Tip Bristles clean along the gum line and between gaps in teeth exceptionally well.
It has a sharp taste of cool mint for a pleasant and lasting freshness, this toothpaste carries out a whitening activity on teeth for a beautiful, brighter smile.
To have a healthy mouth, one needs to take care of more than just teeth. That’s why the Colgate Total Original toothpaste pro-actively fights bacteria not just on the teeth, but also the tongue, cheeks and gums for up to 12 hours* for whole mouth health**. Experience the unique difference of a truly healthier mouth with our best toothpaste for you and your family.
Both Soft and Medium options are yielding to the gums while also delivering deep clean performance. The ergonomic and stylish biodegradable handle is made with 100% Moso Bamboo, a rapidly renewable and biodegradable Giant Grass type with natural antibacterial qualities. Charcoal infused Bristles also help keep bacteria at bay between brushing. Plastic Free white cardboard packaging. VirtueBrush is an Irish Brand established 2016 Dublin.
This original Marvis formula whitens and protects teeth, freshens breath, and helps prevent tooth decay, tartar, and plaque. It has a long-lasting, delightful flavour with a slight tingling sensation, and comes in a distinctive, display-worthy tube that makes the perfect bathroom accessory. Marvis,from Florence, Italy, is a niche dental brand that has been loved in Italy for generations. Marvis is offered in a variety of delicious, innovative, and fashionable flavours, such as Black Forest Mint, Amarelli Licorice Mint and Sweet & Sour Rhubarb Mint. For further information contact: firstname.lastname@example.org
PHARMACYNEWSIRELAND.COM | 65
Zenflore® 2020 & Retail Pharmacy Product Awards
Zenflore® is the world’s first and only supplement harnessing the unique 1714-Serenitas® bacterial culture. Combining the unique 1714-Serenitas® culture with specially selected vitamins, Zenflore® provides support for mind and body through life’s daily challenges. Zenflore:• Aids Mental Performance • Reduces Fatigue
Most Innovative Product It is imperative for many business to differentiate themselves in a packed market whilst addressing customer needs and focusing on what they can do differently. Few markets aren't crowded these days, with competition coming not only from local companies but, thanks to e-commerce, overseas too. In a connected world, services are no longer limited to our local high street. Standing out in a crowded market isn't easy, but innovation can help businesses attract the customers they need to stay ahead of their market competition.
66 | PHARMACYNEWSIRELAND.COM
• Improves Coping The special 1714-Serenitas® culture in Zenflore has been clinically studied in partnership with scientists and clinicians from one of the world’s leading centers of research on the human microbiome. Zenflore’ s special formulation is stable at room temperature and does not need to be refrigerated.
RELIFE Relizema cream
Epitact Flexible Bunion Corrector
Relizema, which helps manage conditions like eczema, dermatitis and dry and sensitive skin, is the first RELIFE product range to be rolled out in pharmacies nationwide. Ireland is the first country in the world outside of Italy to launch RELIFE as a dermatology (over-thecounter [OTC) brand.
The Epitact Flexible Bunion Corrector with EpitheliumFlex® helps to prevent the progression of hallux valgus (bunion) while helping to relieve the symptoms of joint pain.
The Relizema product range, which consists of six products, is aimed at managing eczema, dermatitis and dry and skin conditions in adults and children using a three-pronged approach – ‘Treat, Protect and Cleanse’. RELIFE’s Relizema cream helps to treat the symptoms of itching and redness, which are associated with dermatitis. Due to its dermaprotective action, it helps maintain and restore the physiological skin barrier and its formulation protects and moisturises the skin with a soothing effect.
Bio-Kult Migréa Tackle head discomfort with Bio-Kult Migréa, the latest addition to the BioKult range and the first live bacteria supplement designed to target the head.
Wearing the flexible bunion corrector helps to correct the deformation and limits the development of the bunion. Thanks to its patented design with EpitheliumFlex® technology, the high quality, ultra-thin and lightweight corrector can fit comfortably in most shoes, available in sizes: small, medium and large. It is also reusable and can be machine washed at 30°c in the mesh laundry bag provided. This flexible corrective orthotic acts during walking; on all factors that can aggravate the deformity. For more information please contact: email@example.com
Bio-Kult Migréa is an advanced multiaction live bacteria formulation that targets both the digestive tract and the head and has been formulated with magnesium and vitamin B6, both of which contribute to normal functioning of the nervous system, and reduction of tiredness and fatigue. Vitamin B6 contributes towards the normal function of the immune system and has been shown to help protect against inflammation. Vitamin B6 also has the added benefit of contributing to the regulation of normal hormonal activity. All combined to keep the central nervous system functioning normally.
PHARMACYNEWSIRELAND.COM | 67
BENYLIN® Day & Night Tablets 2020 & Retail Pharmacy Product Awards
Best Cough, Cold and Flu Product The cold and flu season represents one of the biggest revenue generators for the over the counter products market. Global consumer spend was $29billion (source: IQVIA OTC Global Analysis) in 2017 and growing demand of these products are expected to continue for the next five years. It is a huge market, but players also face stiff competition and have a limited window of opportunity to generate these sales. This puts huge pressure on marketing, sales and distribution teams to maximize category management and secure the right “share of shelf,” or risk losing their market potential.
68 | PHARMACYNEWSIRELAND.COM
BENYLIN® Day and Night tablets are the only day & night tablets for 24 hour cold and flu relief. Each white tablet contains 500mg Paracetamol and 60mg Pseudoephedrine hydrochloride. Each blue tablet contains 500mg Paracetamol and 25mg Diphenhydramine hydrochloride. During the day the white tablet relieves fever and decongests the nose. During the night the blue tablet helps relieve cold symptoms for a better night sleep. IRE/BE/20-4063
AlchemLife PhytoRelief-CC™ AlchemLife PhytoRelief-CC™ is a clinically tested, herbal food supplement (12 lozenges). That is a blend of active ingredients selected, formulated and tested to help manage the day; as a natural, seasonal immune support. Containing Pomegranate, TurmericG311 (Curcuma) and Ginger extracts that work in harmony to help support immune function. Based on a traditional Ayurvedic remedy associated with exclusive PhytoAdvance™ technology. Ginger extract helps to maintain a healthy respiratory tract and Gingerol, the active ingredient is known for its antiinflammatory properties. Turmeric which for centuries has been boiled with milk in Ayurvedic medicine to relieve winter ills, helps to control inflammatory response and Pomegranate contains antioxidants such as tannins, anthocyanins and ellagic acid.
Lemsip is the Number 1 Cold and Flu brand in Ireland* and its range of effective cold and flu remedies have been tried and trusted for generations.
Otrivine Adult Mucus Relief Menthol 0.1% w/v is a Nasal Spray that instantly cools the nose with aromatic menthol vapours whilst the active ingredient, xylometazoline hydrochloride, narrows the nasal blood vessels and thereby opens up the nasal passages to work all day. Otrivine Adult Mucus Relief Menthol 0.1% w/v Nasal Spray is for application in the nose and gives effective relief from; nasal congestion (blocked nose, including colds), perennial and allergic rhinitis (recurring inflammation of the nasal mucous membranes, including hay fever) as well as sinusitis.
Over the years our product range has extended, and we offer a wide range of formats from capsules, tablets and liquids to the more traditional hot drink sachets, so you can recommend a product that best suits your patient’s combination of cold and flu symptoms - whether they are aches and pains, sore throat, cough & blocked noses. *Based on IMS unit sales, MAT Nov 2019
The Otrivine brand has recently been refreshed and there has had a significant above the line investment across the 2019/2020 cold and flu season. Otrivine as a brand has grown 35% over the last five years and is a key player in the category. We have big plans for 2020 to keep the brand growing!* *IQVIA OIRMTH, Nasal Decongestant, Value Sales, MAT ending December 19. PM-IE-OTRI-20-00001.
PHARMACYNEWSIRELAND.COM | 69
2020 & Retail Pharmacy Product Awards
Best Children and Baby Product
Calpol 120 mg/5 ml Sugar Free Infant Oral Suspension CALPOL® Infant Sugar Free Suspension is an effective pain and fever reliever that gets to work on a fever in just 15 minutes but is gentle on tummies. The active ingredient in CALPOL® Infant Sugar Free Suspension is 120mg Paracetamol per 5ml suspension which provides gentle, effective relief from fever, pain, blocked nose, ear ache, cold symptoms and flu symptoms. Trusted by parents for over 50 years, CALPOL® Infant Sugar Free Suspension is gentle enough to use from 2 months and each pack comes with an easy dose syringe. IRE/CA/20-4064
Baby care and child-specific products have an important role to play in pharmacy particularly in Ireland as birth rates here are currently higher than the EU average. The birth rate in Ireland remains relatively high this year with 14.4 babies born per 1,000 residents compared to an average of 10.1 in the rest of the EU. By offering good advice from birth onwards, pharmacy teams can play a vital role in helping parents deal with the many self-limiting ailments that occur during childhood. These conditions range from colic to paediatric cold and flu.
70 | PHARMACYNEWSIRELAND.COM
MyPro™ Kolicare MyPro™ Kolicare is a clinically proven probiotic formula that effectively prevents and treats the early childhood indications of colic, whilst promoting a healthy digestive system for baby. The 100% natural, safe and easy to use formula supports babies’ gut microbiota maturation. It is suitable for both formula and breast-fed babies and is allergen free. • For babies, infants and children, from 0+ months. • 5 drops a day and can be mixed with warm milk. • Formulated with two different strains of probiotic bacteria with targeted benefits. Tested daily dose 1 billion CFU(1E9). • Clinically proven to; reduce episodes of colic and babies daily crying time. Increase gut bacteria diversity, improve GI transit and is non-bloating. For further information contact: firstname.lastname@example.org
RELIFE Relizema spray&go
WellKid Soft Jelly Pastilles
RELIFE is a Menarini Group dermatology and aesthetics medicine division. Relizema, which helps manage conditions like eczema, dermatitis and dry and sensitive skin, is the first RELIFE product range to be rolled out in pharmacies nationwide.
Wellkid Soft Jelly Pastilles are developed by the UK leading vitamin supplier, Vitabiotics.
RELIFE is a new approach to skincare, where specialised science meets and helps manage common skin conditions. The two Relizema baby-range products include a spray and baby-care cream which have zinc and panthenol, specifically formulated to protect the delicate and sensitive skin of children. Both are ideal to help soothe and prevent the reddening and burning sensation in the nappy area.
They are not just a great source of 11 important nutrients – they’re super yummy, too! Wellkid Soft Jelly pastilles provide a multivitamin formula to help safeguard the nutritional intake of children aged 4-12 and are available in two great tasting flavours: Strawberry and Orange. No other supplement for children provides 11 vitamins plus flaxseed oil. Wellkid Soft Jelly includes all eight B-complex vitamins plus vitamin C, D and E.
Bronchostop Junior Introducing Bronchostop Junior fast acting relief for ANY cough* in children from one year. Bronchostop soothes the cough reflex in stages of both dry and productive chesty cough by covering the cough receptors with a protective layer of marshmallow extract and honey. Traditionally, productive and non-productive coughs have been managed differently but the ingredients in Bronchostop Junior work in synergy to relieve both dry and chesty coughs* Bronchostop Junior is a medical device.*associated with a cold.
RELIFE’s Relizema spray&go - zinc + panthenol is a protecting and soothing spray suitable for delicate and sensitive skin of babies and adults.
PHARMACYNEWSIRELAND.COM | 71
Emazole Control 2020 & Retail Pharmacy Product Awards
Best Launch of the Year When launching a new product there are several steps to success that are crucial for any business, taking time and careful planning. These include understanding your target audience and how to reach them effectively, looking at what makes your product innovative or different and unifying the product team across all channels, whether itâ€™s marketing, social media or sales. The finalists in this category have demonstrated that consistency is key when launching a new product within the OTC market.
72 | PHARMACYNEWSIRELAND.COM
Emazole Control 20mg Gastro-resistant tablets 7s & 14s (active ingredient: Esomeprazole) was launched in November 2019 by Rowex Ltd. The therapeutic Indications are: Proton Pump Inhibitor (PPI): Short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults. Emazole Control 20mg Gastro-resistant tablets 7s & 14s is one tablet daily, providing 24hour lasting relief from frequent acid reflux and heartburn.
Triumph® Monthly Cycle Supplement Created by women for women, Irish made Triumph® Monthly Cycle Supplement is ‘The Ultimate All-In-One Beauty, Energy, Hormonal Activity & Immune System Support Supplement.’ This is the first product in the world that’s designed around the three phases of the monthly cycle. Made in Ireland and containing a months supply of 30 sachets and 30 tablets, all numbered, colour coded and easy to take. Triumph ingredients include CoQ10 (Ubiquinol), Vitamin A, B, C, D, E, K2, Biotin, Iron, Zinc, Folate, Chromium, Magnesium, Green Tea, Maca, Grape Polyphenols, Citrus Bioflavonoids, Shatavari, Amino Acids, Lycopene, French Maritime Pine Bark & more 3 different formulations in 1 monthly programme Over 55 Highly Bioavailable ingredients to support Energy, Hair, Skin, Nails, Hormonal Activity, Heart Health and the Immune and Nervous Systems Suitable for vegetarians, sugar free and from age 12 up to menopause
Broncho Junior Introducing Bronchostop Junior fast acting relief for ANY cough* in children from one year. Bronchostop soothes the cough reflex in stages of both dry and productive chesty cough by covering the cough receptors with a protective layer of marshmallow extract and honey. Traditionally, productive and nonproductive coughs have been managed differently but the ingredients in Bronchostop Junior work in synergy to relieve both dry and chesty coughs* Bronchostop Junior is a medical device.*associated with a cold.
RELIFE Relizema Range – Consumer Campaign 2019 IFP Media Ltd, one of Ireland’s most experienced and trusted specialist communicators, is responsible for building the RELIFE Relizemabrand in Ireland with A.Menarini Pharmaceuticals Ireland Ltd. The objective of IFP Media Ltd and Menarini’sRELIFE Relizema Consumer Campaign 2019 included driving awareness of a new dermatology brand to be launched in Q2 in Ireland and educating the target audience – ABC1 2565, young mothers 30-40, and proactive shoppers in this category – on the health benefits of managing skin-related issues. IFP Media Ltd focused on brand awareness and patient education through creating bespoke and native content with print, digital, social and broadcasting media. The resulting consumer campaign key performance indicators for 2019 showed a total reach of 2,210,191.
PHARMACYNEWSIRELAND.COM | 73
Solgar & Nature’s Bounty Training The Nature’s Bounty Company seeks to build consultative relationships with pharmacies, helping them to develop an understanding of the supplements category and as well as the product knowledge and selling skills to offer a great customer experience.
2020 & Retail Pharmacy Product Awards
Best Pharmacy Training Initiative of the Year Excellence in training initiatives is a crucial component for many pharmaceutical companies in the promotion of their OITC offering, whether it be for an existing or a new product and/or service. Training presents a prime opportunity to expand the knowledge base of your audience, ensuring consumers enjoy a consistent experience and background knowledge.
Training needs are met through a blend of online learning, in-store training and workshops. The dedicated Category and Product Training team strive to build a training plan that meets the individual needs of each customer by taking time to understand their current knowledge level, business goals and shopper demographics with the overall objective being not just to grow sales of Nature’s Bounty Company brands, but the whole vitamin, mineral and herbal supplements category. The Nature’s Bounty Company manufactures and distributes the award-winning Solgar and Nature’s Bounty brands providing a broad range of supplements for both premium and mainstream consumers.
THE SOLGAR® ACADEMY LEARNING HUB
AC A D E M Y
N EAR GET TS & POIN ARDED REW OR F G ININ TRA
24/7 Access to the Best Training and Education Resources: Webinars, E-Courses, Training Manuals & Nutrition News REGISTER NOW at www.solgaracademy.co.uk to enrol in courses, complete assessments and earn great rewards For more information contact your Solgar® Territory Account Manager or call 01442 890 355 Food supplements should not be used instead of a varied balanced diet and a healthy lifestyle. Solgar® is a registered trademark.
THE SOLGAR® ACADEMY LEARNING HUB N EAR GET TS & POIN ARDED REW OR F G ININ TRA
74 | PHARMACYNEWSIRELAND.COM
AC A D E M Y
Uriage, the pharmacy only dermo-cosmetic brand, is one of the leading thermal water brands on the international market. Uriage products respond to the needs of all skin types including the most sensitive.
KELO-COTE® is an advanced formula silicone scar treatment. Clinically proven to soften and flatten raised scars as well as reducing discolouration and redness, KELO-COTE® can be used to treat existing scars or to help prevent new scars from forming, if used as soon as the wound is closed or stitches are removed.
4FrontPharmacy.ie clients have demonstrated increased sales, staff engagement and regulatory compliance by using our cutting edge online training platform to improve the quality of their patient/pharmacy interactions.
Uriage Thermal water cannot be compared to others sold in Ireland. Uriage is committed to providing ongoing training to ensure that all pharmacy staff are confident they can offer the best possible advice and service to customers. Uriage 360 training comprises of onsite training of pharmacy staff, monthly off site training in key locations nationwide, online training support. Uriage invested in a knowledge based competition over several months resulting in over 13 pharmacies being represented on a trip to France for an experiential trip to the Uriage Thermal Centre.
KELO-COTE®’s patented formula binds to the skin’s surface creating an ultrathin sheet which can give treatment and protection for 24 hours per day. Once applied it dries within just 5 minutes.
4FrontPharmacy leads the field in ‘whole of pharmacy’ team education. Its engaging audio-visual modules are independently produced. It has an extensive range of topics relevant to pharmacy teams. Filmed consultations model practical application and learner tracking supports engagement and professional oversight. To find out more about joining 4FrontPharmacy’s award-winning pharmacy development programmes to equip, empower, enable and engage you and your pharmacy team(s) to become who you need to be, do what you need to do and demonstrate the expertise you need to deliver on your customer promise, contact Rachel.Dungan@4FrontPharmacy.ie
PHARMACYNEWSIRELAND.COM | 75
2020 & Retail Pharmacy Product Awards
Best Marketing Campaign of the Year Marketing campaigns are the perfect way to reach customers, clients, and leads. They can be the gamechanging move. Producing campaigns with a series of touchpoints will grab someone’s attention better than a single advertisement. With a need to break through the clutter when promoting a product , an effective marketing campaign can do that for you.
Spotlight SL Consulting – Harm Free Oral Health Spotlight is a new range of toothpastes, created by two Galway based dentists in response to the potentially harmful ingredients found in most other brands. Research showed we all take it for granted that our toothpaste ingredients are safe. So the aim of the launch campaign was to wake consumers up about what’s actually in their existing brand and get them to reconsider what they're putting into their mouths, one of the most absorbent parts of the body. Focusing on the toothpaste’s unique formulation, the TTL campaign which featured Spotlight’s creator’s Dr Lisa and Dr Vanessa Creaven, was extremely effective in not only raising awareness of this new challenger brand but also in driving engagement, increasing site traffic and improving sales.
The Best Marketing Campaign Award recognises a marketing, PR or advertising campaign that has proved to be original, innovative and particularly effective. This can be a one-off campaign or part of a sustained strategy.
76 | PHARMACYNEWSIRELAND.COM
Durex Valentines Campaign Durex Natural Gel is a 100% natural gel designed to make sex feel smooth and naturally thrilling. Durex Natural gel has a water-based formula making it pH friendly and is free from all irritants and synthetic ingredients. Durex Natural has no added fragrances or colours and works with customers bodies to make sex more comfortable and smoother. The product contains pre-biotics which help maintain the skin balance and is suitable for any type of sex. The minimalist and natural looking packaging aims to reduce the taboo of using lubricants during sex making it more socially acceptable to use regularly during sex, particularly having women more comfortable in saying that they want/ need it.
NiQuitin NiQuitin offers a range of products specifically designed to help customers stop smoking. The NiQuitin range includes NiQuitin Clear patches which are available in three different strengths – 21mg, 14mg, and 7mg. NiQuitin patches provides 24 hours of controlled nicotine release and helps you stay in control of your nicotine cravings. NiQuitin Mini Lozenges are available in two strengths 1.5mg and 4mg. NiQuitin Mini Lozenges are designed for smokers who want discreet craving relief for situations where they can’t smoke. NiQuitin Mini Lozenge are available in convenient pack for on the go cravings.
Perrigo Cold & Flu Products Perrigo Cold & Flu products are designed to relieve all your cold and flu symptoms. The range contains the only max, strength, triple active sachet. Uniquely designed it eases the common symptoms associated with a cold and flu including aches & pains, fever, chesty cough, congestion and sore throat.
Solgar Campaigns Solgar®, the world’s leading premium vitamin and supplement brand, is proud to launch Ultibio Immune, an innovative formula scientifically proven to support the immune system during cold winter months. To support the successful launch of Ultibio Immune, we are at Solgar® have invested significant and developed marketing materials, whether promoting the in store or online there is something for consumers to use. From free Poster, shelf talkers, counter display units to online social media assets like GIFs and images for Instagram and Facebook. As a seasonal product, Ultibio Immune is most relevant during the winter months, however as an immune support supplement, this is an all year product. The passion and commitment of Solgar® and the people who buy our products has not changed for over 70 years. That’s why we sell more innovated supplements in more countries around the world than any other supplement brand. And it’s also why 98% of consumers recommend Solgar®*. *Global Praxis online shopper survey 2017 of 3,882 VMS consumers in eight EU countries.
Stay well this winter with Ultibio Immune Scientifically proven ingredients to balance and maintain the immune system* *See pack for details. Food supplements should not be used instead of a varied balanced diet and a healthy lifestyle. Solgar® is a registered trademark.
Stay well this winter | 77 PHARMACYNEWSIRELAND.COM with Ultibio Immune
Voltarol Emulgel Extra Strength 2% w/w Gel 2020 & Retail Pharmacy Product Awards
Best Pharmacy Only Brand While more is being done to promote awareness regarding the importance of the safety and appropriate use of OTC drugs, pharmacists are still the patients best resource in the proper selection of OTC products. Moreover, while it is important for all patients to properly use OTC products, individuals of advanced age, individuals with pre-existing medical conditions such as diabetes, those currently using prescription drugs and those requiring pharmacy-only products must always consult their pharmacist when considering the use of OTC drugs to avoid possible contraindications, drug interactions, and/or dosing errors.
78 | PHARMACYNEWSIRELAND.COM
Unlike products that work by only cooling or heating the skin, Voltarol Emulgel Extra Strength 2% w/w Gel contains a non-steroidal anti-inflammatory drug (NSAID), called diclofenac. Voltarol 2% Gel is applied locally, targeting pain at the source. It works by blocking production of some of the body’s chemicals that cause inflammation, pain, tenderness and swelling. This product introduced innovation to the market in 2016 and continues to improve joint pain sufferers’ lives. With a ¤600k marketing investment in 2018, Voltarol drove the Topical Pain Category in Pharmacy and encouraged consumers to have conversations with pharmacists about managing their joint pain.
Nexium Contol Nexium Control is Ireland’s No.1 pharmacy-only heartburn treatment without prescription* and is one of the fastest growing brands in the GI category. Since its launch in 2014, it has grown from strength to strength and now accounts for 39% value market share and continues to experience double digit growth of 14%year ending December 2019. The brand has continued to innovate introducing the mini capsule in 2018 which is an easy to swallow capsule in a convenient bottle format. A high level of continued marketing support above and below the line is driving its’ overall success together with continued pharmacy support from the Pfizer Consumer Healthcare representative team. Full product details available on medicines.ie For Pharmacy only. * IMS Data Dec 2019 MAT Value Sales PP-NEX-IRL-0109
Nurofen Rapid Relief Liquid Capsules
BENYLIN® Day & Night Tablets
It has been a strong year of growth for the Nurofen brand in pharmacy. The big news of 2019 was the launch Nurofen Rapid Relief Liquid Capsules in February, which was supported by an extensive education program and backed by a highly effective above the line campaign.
BENYLIN® Day and Night tablets are the only day & night tablets for 24 hour cold and flu relief. Each white tablet contains 500mg Paracetamol and 60mg Pseudoephedrine hydrochloride. Each blue tablet contains 500mg Paracetamol and 25mg Diphenhydramine hydrochloride. During the day the white tablet relieves fever and decongests the nose. During the night the blue tablet helps relieve cold symptoms for a better night sleep.
125 Million pain occasions were treated by Irish Pharmacy over 12 months and 40 million of these were treated with Nurofen. * Nurofen Rapid Relief Liquid Capsules were launched in February 2019 providing over the counter fast and effective pain relief to patients. ** Nurofen now accounts for 44% of the Mild Pain market. ***
*IMS Data Aug 2019 **Nurofen Rapid Relief Maximum Strength 400mg Liquid Capsules contain Ibuprofen. For pain relief. Always Read the Label. ***IMS Data June 2019 ZINC No. IRL/CC/1219/0039. Date of preparation: Dec 2019
PHARMACYNEWSIRELAND.COM | 79
Optrex Pro Vision 2020 & Retail Pharmacy Product Awards
Best Eye Care Product Consistently strong growth is expected within OTC Eye Care market in the future. Screen time is having a negative impact on consumersâ€™ eyes, which often dry out and become sore. Innovation is likely to also fuel growth over the coming years. Many Irish consumers suffer from eye conditions such as blepharitis, where the eye lid becomes blocked and enflamed. Furthermore, Ireland experienced a prolonged period of hot weather last year, with temperatures soaring above average and partial drought conditions being experienced across most of the country. This had a positive impact on overall sales of allergy eye care in particular as demand increased due to the high pollen count in the country.
80 | PHARMACYNEWSIRELAND.COM
Optrex Pro Vision contains Lutein and Zeaxanthin which act in two ways: first as filters for damaging blue light, and second as antioxidants quenching excited triplet state molecules or singlet molecular oxygen and scavenge further reactive oxygen species like lipid peroxides or the superoxide radical anion. Optrex Pro Vision also contains Vitamin A which plays a crucial role in vision by maintaining a clear cornea, which is the outside covering of the eye. Also containing Magnesium which relaxes the smooth muscle in the eye. Eyelid twitching and other spasms of the eye, including a condition called Blepharospasm, can often be remedied with continued magnesium supplementation and protects the optic nerve from overstimulation.
Hy-Opti Eye Drops Hy-Opti Eye Drops are a moisturising ophthalmic solution available in 10ml and 20ml containing sodium hyaluronate. Hy-Opti Eye Drops are preservative free and provide soothing relief from the effects of dry-eye. The unique selling points for Hy-Opti include: • Fast acting moisturising ophthalmic solution • Available in 10ml and 20ml • Hy-Opti Eye Drops are preservative free and provide soothing relief from the effects of dry-eye. The product is innovative as we offer two strengths, 10ml and 20ml at a lower cost than the brand leader • Investment for the brand includes: • Trade advertising with IPN. • Pharmacy flyers. • Information leaflets.
OPTASE® TTO Eye Lid Cleansing Gel
OPTASE TTO Eye Lid Cleansing Gel is a gentle and preservative free, Tea Tree Oil (TTO) based eye lid cleanser, providing natural relief from the symptoms of Blepharitis. OPTASE™ TTO Cleansing Gel contains a unique formulation of Tea Tree Oil, Hyaluronic Acid & Pro-Vitamin B5 which are preservative free, making it ideal for daily lid hygiene. Pro-Vitamin B5, also known as Panthenol has moisturising properties that can help to keep skin in good condition OPTASE® TTO Eye Lid Cleansing Gel should be used as part of your daily dry eye regime. • Keeping your eyelids and lashes clean helps keep eye lid crusting and excess oils under control. • Clean healthy eyelids are essential in order to produce healthy tears and avoid irritation. • The gentle concentration of Tea Tree Oil and Pro-Vitamin B5 is soothing for tired, dry, and sore eyes. • Part of the HEAT, CLEANSE, HYDRATE Regime ®
Macu-SAVE™ a once a day, easy to swallow food supplement; helps to provide advanced nutrition for the eyes with all three key macula carotenoids. As we grow older our eye health comes under increasing pressure and in particular; the macular, the most delicate part of the retina can become damaged. Boosting the diet and enriching the macular pigment with macula carotenoids; Lutein 10mg, Zeaxanthin 2mg and Meso-Zeaxanthin 10mg. These are found in high concentrations at the back of the eye within the macular pigment, which protects against damaging visible blue light or oxidative stress. For further information contact: email@example.com
PHARMACYNEWSIRELAND.COM | 81
Professional Fast Tanning Mousse 2020 & Retail Pharmacy Product Awards
Best Tanning Product
Ideal for those who like a quick fix tan, the St. Moriz Professional Fast Self Tanning Mousse allows wearers to control their shade. Achieve a light, sunkissed glow in just 1 hour or wait 2 hours for a medium tan and 3 hours for a dark tan. Easy to apply, it develops in as little as an hour for a natural glowing tan. Fast Tanning Mousse is a streak-free formulation and has a fabulous, fresh fragrance. Also contains olive milk and Vitamin E to nourish and protect the skin. With shade control. Dermatologically tested.
The self-tanning market is still booming, not just in Ireland but globally. With an increase in the number of cases of non-melanoma skin cancer, consumer awareness around long-term sun exposure is increasing and, along with it, the willingness to use self-tanners. As the lines between self-tanning and skincare categories continue to blur, innovation in formulation and product ranges will remain paramount to the success of the self-tanning market, say market research reports.
82 | PHARMACYNEWSIRELAND.COM
WHITE to BROWN Self Tanning Water Medium For this product, the experts at WHITE to BROWN have created a unique transparent tanning base that dries instantly and transforms into a radiant glow within a few hours. Enriched with coconut extract and aloe vera, the refreshing water-based formula is lightweight with a delicate coconut scent and a streak-free application. Created specifically for a fuss-free use, this clean application means no transfer so wearers can glow and go! Here at WHITE to BROWN, we want our bespoke self-tanning formulations to bring a little everyday luxury to your beauty routine. We combine the finest skin-boosting formulations with superior tanning techniques for body confidence you can flaunt without filters! Whatever your tone, we promise there is a beautiful tan waiting for you.
Perfect Fade Vegan Self-Tan Oil
TanOrganic Facial Tan Oil
Magic Mousse à Bronzer
Perfect Fade Vegan Self-Tan Oil by Cocoa Brown is a luxurious tanning oil that sets instantly and develops within 2-3 hours to create a smooth, bronzed glow. It gives skin the ultimate natural-looking, hydrated and radiant glow that lasts for up to 7 days and fades perfectly.
TanOrganic Facial Tan Oil is a luxurious self-tan specially formulated for the delicate skin on the face that absorbs quickly without leaving a greasy layer to reveal a radiant natural golden tan.
The amazing tan activator Magic Mousse à Bronzer is a milky foam that gradually prepares skin to tan one month before exposure. Prepare the skin and tan more quickly with Sunny Magic Mousse à Bronzer. Wearers will fall for this airy mousse scented with delicate notes of bergamot, honey, jasmine and vanilla. Application feels truly indulgent. It smooths the skin texture, making it more supple and preparing it to tan evenly. Its ultra-light, creamy mousse texture becomes a melt-in oil that feels comfortable on skin. This creamy mouse is ideal for all skin types.
It moisturises, leaving the skin feeling soft and smooth with a gorgeous bronzed colour. Perfect Fade Self-Tan Oil is available in one shade medium.
Made wholly from natural and organic ingredients that are super nourishing, it will leave skin looking and feeling hydrated for up to 7 days. It is suitable for sensitive skin, eczema-prone, acne or psoriasis. The World’s FIRST and ONLY ecocertified, vegan certified, organic and cruelty-free self-tan. Along with being the highest-rated self-tan on trust pilot, it is also the only tan with a 100% score with ethical association; only 6 other cosmetic brands in the planet have such a score.
Star active ingredients: Orange AHA Sea buckthorn oil Dog rose extract Coconut oil
PHARMACYNEWSIRELAND.COM | 83
Triumph® Monthly Cycle Supplement 2020 & Retail Pharmacy Product Awards
Best Women's Health Product Health issues and care strategies for women’s health is far more wide-reaching than just pregnancy and gynaecology. Research has shown that increased global focus on women’s health disorders and an overall aging female population are helping to drive growth of the women’s health products over-the-counter.
Created by women for women, Irish made Triumph® Monthly Cycle Supplement is ‘The Ultimate All-In-One Beauty, Energy, Hormonal Activity & Immune System Support Supplement.’ This is the first product in the world that’s designed around the three phases of the monthly cycle. Made in Ireland and containing a months supply of 30 sachets and 30 tablets, all numbered, colour coded and easy to take. Triumph ingredients include CoQ10 (Ubiquinol), Vitamin A, B, C, D, E, K2, Biotin, Iron, Zinc, Folate, Chromium, Magnesium, Green Tea, Maca, Grape Polyphenols, Citrus Bioflavonoids, Shatavari, Amino Acids, Lycopene, French Maritime Pine Bark & more 3 different formulations in 1 monthly programme Over 55 Highly Bioavailable ingredients to support Energy, Hair, Skin, Nails, Hormonal Activity, Heart Health and the Immune and Nervous Systems Suitable for vegetarians, sugar free and from age 12 up to menopause
Today’s women are much more well informed with consumers leaning towards self-care and self-medication and thus the outlook has been witnessing a dramatic transformation in recent years.
84 | PHARMACYNEWSIRELAND.COM
Relactagel Relactagel is a product for the treatment and prevention of Bacterial Vaginosis (BV), the most common cause of abnormal vaginal discharge in women of childbearing age, but may also be encountered in menopausal women. Unlike other products, Relactagel treats within 7 days and prevents recurrence of infection when used as a maintenance therapy. Containing natural Lactic Acid, Relactagel restores a natural pH balance that encourages the growth of Lactobacilli that maintain a healthy vagina, getting rid of the fishy odour and stopping the abnormal discharge. Each Relactagel pack contains 7 easyto-use single dose applicators for a full week’s treatment. Relactagel is made in Ireland by a fully owned Irish Company.
Proceive® Women is an advanced fertility supplement designed to support the nutritional needs of women when trying for a baby, whether they have just started or have been trying for a while.
Vagisil Crème is an intimate cream delivering Instant, long-lasting relief from intense itch, especially itch associated with antibiotics, discharge, imbalance in PH and irritating vaginal conditions.
Based on research by fertility experts using over 600 clinical studies, Proceive® Women provides 1,416mg of 28 carefully selected amino acids, vitamins and minerals, including folic acid, to support the myriad of processes involved in egg production, womb preparation, hormone regulation and more.
For over 40 years, Vagisil has been on a mission to improve the intimate health of women. Around the world, they have seen first-hand that when women take charge of their intimate health, have access to effective products and accurate information, they are more focused, productive, comfortable and confident. It enables women to be at their best.
An Irish brand, Proceive® Women provides one of the most comprehensive formulation available, tailored specifically to support pre-conception health for all women trying for a baby.
The Brand has three key pillars, Itch, Odour & Freshness. The Vagisil intimate Crème falls under the itch category. The product launched on the Irish market in 2018.
Active Iron & B Complex Plus for Women Active Iron & B Complex Plus for Women is specially designed for women to help tackle tiredness and support hormonal balance. Active Iron & B Complex Plus for Women combines the non-constipatingActive Iron formula with a high strength multivitamin. Active Iron & B Complex Plus for Women has clinically proven twice the absorption of standard ferrous sulphate and contains a specially formulated multivitamin complex with a targeted delivery system to improve absorption. Active Iron & B Complex Plus for Women helps tackle tiredness and supports hormonal balance, healthy skin, hair and nailsas well as mental performance and immunity.
PHARMACYNEWSIRELAND.COM | 85
Zest Active 2020 & Retail Pharmacy Product Awards
Best VMS Product Increasing numbers of people are taking a proactive approach to their health and the wellbeing trend is sweeping the nation. Keeping up with consumers or even getting a bit ahead of their desires is the name of the game. In the ever-changing and extremely fickle vitamins, minerals and supplements (VMS) category, it is even more vital to stay on pace or ahead of the curve with those visiting their local pharmacy. According to latest market research reports, vitamins sales are expected to continue growing as consumers increasingly look towards preventative measures over cures. A growing number of consumers are expected to monitor their health through blood tests, which will result in greater awareness of vitamin and other deficiencies.
86 | PHARMACYNEWSIRELAND.COM
Zest Active is a powerful and innovative super supplement from Irish Supplement company Revive Active. Zest Active contains 25 active ingredients that support a busy lifestyle contributing to sustained energy, muscle, brain and immune system support. Delivered in powdered form this supplement works by supplying the body with the essential nutrients required for optimum health. Itâ€™s a comprehensive blend of multifunctional ingredients including amino acids, vitamins, minerals and Wellmune a beta 1,3/1,6 glucan, taurine, l-glutamine and l-lysine. Each sachet contains a carefully selected range of B Vitamins (Riboflavin (B2), Niacin (B3), Pantothenic Acid (B5), B6, Folic Acid (B9), B12 which ensures that Zest Active contributes to a normal energy-yielding metabolism. It contains a natural sweetener, steviol glycosides and is suitable for vegetarians, vegans, diabetics and gluten free diets as well as being Informed Sport approved. Containing no caffeine, binders or fillers this refreshing orange flavoured blend provides daily nutrient needs.
Aqua Biome The team at Aqua Biome believe in quality research to create potent and effective solutions. The unique Aqua Biome™ formulas are based on cutting edge science to go the furthest in benefiting complete health by providing the optimal ratio of Omegas DHA, EPA, and DPA. Having these in the proper ratio for human health is now understood to be more important than high dosages alone. Aqua Biome™ is the world's first fish oil with DPA, "missing omega" that other fish oils don't know about. This crucial omega can be converted to either DHA or EPA by your body in an instant. RSP starts at: ¤33.99
Eskimo Brain 3.6.9
Sevens seas Jointcare Supplex & Tumeric The only product to combine Turmeric extract with Glucosamine & Omega-3. Seven Seas JointCare® Supplex® & Turmeric has been formulated with: • Vitamin C contributes to normal collagen formation for the normal function of bones and cartilage • Vitamin D to help maintain normal bones • Vitamin C to support the normal function of the immune system • Manganese contributes to the normal formation of connective tissue Features - Support for Cartilage (Vitamin D); Bones (Vitamin D), Muscles (Vitamin D), Connective Tissue (Manganese). Seven Seas has been supporting family health since 1935 and Seven Seas JointCare® experts understand how important it is to have support so people can continue doing the things they love.
Whether someone is doing exams or just looking to increase brain power, Eskimo Brain 3.6.9 is the food supplement for them. Omega-3 DHA is brain food. Just as calcium is essential for building strong bones, 250mg DHA daily is essential for good brain health. DHA helps to improve learning, mood, memory and concentration. With high levels of omega-3 DHA along with Omega-6 and -9 from seed oils, vitamin D, E and CoQ10, those taking it will feel focused in no time. Taking a daily fish oil supplement, naturally rich in omega-3, can support the heart, brain, joints and skin and is a simple way to safeguard health. Eskimo-3 is committed to delivering safe, sustainably sourced, effective omega-3. www.eskimo3.ie
PHARMACYNEWSIRELAND.COM | 87
Lombastab Lumber Support 2020 & Retail Pharmacy Product Awards
The Lombastab is a premium lumbar support belt that helps manage low back pain in the acute phase allowing wearers to keep active and maintain their lifestyle. Over 80% of the population suffer from low back pain at some stage in their lives. The Lombastabâ€™s unique and innovative design provides even support around the spine taking the pressure off spasming muscles and ligaments.
Best Living Aid/Medical Device Product Retail pharmacy is not only limited to offering OTC medicines and cosmetics; this new category for 2020 highlights those living aid and medical device products available to purchase in community pharmacies across Ireland. These products assist with enhancing and improving consumer health and wellbeing and can include sport supports, electronics and non-medicated therapies.
88 | PHARMACYNEWSIRELAND.COM
The anatomically shaped stays provide a comfort fit and the quick lacing system allows the wearer to easily adjust compression during the day depending on their activity. The Lombastab is available with attractive retail friendly free-standing display units from New Vision Healthcare: contact firstname.lastname@example.org.
Duracell EasyTab Hearing Aid Battery
Epitact Flexible Bunion Corrector
Scholl InBalance Pain Relief Insoles
Duracell EasyTab Hearing Aid Battery is easy to hold, replace and remove. An extra-long tab makes it simple to handle and its lightweight packaging is easy to open.
The Epitact Flexible Bunion Corrector with EpitheliumFlex® helps to prevent the progression of hallux valgus (bunion) while helping to relieve the symptoms of joint pain.
Scholl InBalance Pain Relief Insoles help to relieve lower body pains from being on the feet all day.
EasyTab hearing aid batteries are colourcoded in yellow, orange, brown and blue, so wearers won’t have any trouble finding the size right for them.
Wearing the flexible bunion corrector helps to correct the deformation and limits the development of the bunion. Thanks to its patented design with EpitheliumFlex® technology, the high quality, ultra-thin and lightweight corrector can fit comfortably in most shoes, available in sizes: small, medium and large. It is also reusable and can be machine washed at 30°c in the mesh laundry bag provided.
Duracell’s lightweight yet strong protective packaging keeps the batteries safe and secure. Duracell Hearing Aid Batteries last up to 4 years in ambient storage and they contain 0% Mercury.
Developed with a team of biomechanic experts, they have a Motion Control Structure and have been designed to work in three ways: Shock absorption, pressure redistribution and stabilisation. Lower Back Pain relief insole comes with a heel cup to reduce stress transfer to the lower back. It is a full length insole to support the position of the entire foot and prevent high pressure areas, distributing the load more evenly.
This flexible corrective orthotic acts during walking; on all factors that can aggravate the deformity. For more information please contact: email@example.com
PHARMACYNEWSIRELAND.COM | 89
Pharmed Window Display Competition Pharmed have recently announced details of their February/March 2020 Window Display competition, with entries now open to all community pharmacies across Ireland. Store criteria: 1 entry per store Open to Independent Pharmacy and small groups up to 10 stores To qualify for entry each store must have a minimum of 3 packs of all 4 SKU’s (Active Iron, Active Iron & B Complex Plus for Women and Active Iron & B Complex Plus for Men, Active Iron Pregnancy) on the shelf during the promotion period. Photographic evidence of the completed Window must be provided, and the window must remain in place for a minimum of 7 days Promotion period will run from February 4th to March 27th 2020. Final entry and start date will be 13th March 2020 Pre orders can be taken now.
All entrants must take a minimum of one full POS kit (Core or M&W) All entrants can take a maximum of two full POS kit (Core and M&W) Winners will be chosen by Solvotrin/Pharmed Management from photographic evidence after the close of the competition and winners announced no later than 30th April 2020. Prize: Store prize will be vouchers to the total value 250 euro which should be used for the benefit of all store staff Contacts for entry Leinster - Andrea Murphy firstname.lastname@example.org 087-2288359 Munster Moya McCarthy - Power email@example.com 086-4114597 Connaught - Ursula Brooks firstname.lastname@example.org 086-0235901 Previous entries to the Pharmed Window Display Competition
Eliminates head lice and eggs with hands-free disposal Chemical-free with biodegradable capture filters Detects & prevents infestations with visible results Streamlined and user-friendly with dual combing angles
CHEMICAL-FREE HEAD LICE TREATMENT WITH THE EASE OF COMBING
For more information or to place an order contact Brandshapers
90 | PHARMACYNEWSIRELAND.COM
V-Comb® A1 is a patented and design registered product. V-Comb® is a registered trademark. ©2019 ToLife Technologies Pty Ltd.
Phone: 053 91 79007 email@example.com
NEW Relizema™ ECZEMA DRY & SENSITIVE SKIN BABY CARE
A unique range of Italian emollients and cleansers, which includes products developed for eczema, dermatitis, baby care, dry and sensitive skin.
ORDER NOW OMAURA CRONIN
086 – 8198271 Maura.Cronin@united-drug.com
086 – 8198271 Mervyn.Connaughton@united-drug.com
087 - 0524507 Yvonne.Quigley@united-drug.com
All products are dermatologically tested
Distributed by: A.Menarini Pharmaceuticals Ireland Ltd, Castlecourt, Monkstown Farm, Monkstown, Glenageary, Co. Dublin.
IE19031 IR-REL-49-2019 Date of item August 2019